Nitrogenated heterocyclic compound and agricultural or horticultural fungicide
Patent Information
- Application Number
- LAP290
- Authority / Receiving Office
- LA · LA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2011-05-20
- Filing Date
- 2012-05-17
- Publication Date
- 2025-12-12
AI Technical Summary
Conventional agricultural and horticultural fungicides often have insufficient control efficacy, cause phytotoxicity, contamination, and toxicity to humans, livestock, and the environment, and are not effective against drug-resistant pathogens.
Development of nitrogen-containing heterocyclic compounds represented by specific formulas, which are used as active ingredients in fungicides, providing effective control of fungal diseases with minimal toxicity and environmental impact.
The nitrogen-containing heterocyclic compounds offer reliable and safe fungicidal activity with broad-spectrum efficacy against various fungal diseases, including those resistant to other fungicides, while minimizing harm to plants, animals, and the environment.
Abstract
Description
[0001] The present invention relates to a fungicide for agricultural and horticultural use that has a reliable effect and can be used safely, and a nitrogen-containing heterocyclic compound useful as an active ingredient of the fungicide for agricultural and horticultural use. This application claims priority based on Japanese Patent Application No. 2011-113174 filed in Japan on May 20, 2011, Japanese Patent Application No. 2011-143478 filed in Japan on June 28, 2011, Japanese Patent Application No. 2011-254368 filed in Japan on November 21, 2011, and Japanese Patent Application No. 2011-274141 filed in Japan on December 15, 2011, and incorporates the contents thereof herein.
[0002] A number of control agents are used against diseases of agricultural and horticultural crops. However, many of the conventional control agents have insufficient control efficacy, their use is restricted due to the emergence of drug-resistant pathogenic bacteria, they cause phytotoxicity or contamination to plants, or they have a large toxicity to humans, livestock, fish, or an impact on the environment, etc., and thus are not fully satisfactory. Therefore, the emergence of drugs with fewer such drawbacks is strongly desired. In relation to the present invention, Patent Document 1 discloses the following formula:
[0003] (In the formula, R 1 and R 2 represent an alkyl group or the like, R 3 and R 4 represent a hydrogen atom, a halogen atom or the like, R 5 represents a hydrogen atom, an alkyl group or the like, X 1 represents a halogen atom, an alkyl group or the like, Y 1 represents a halogen atom, an alkyl group or the like, n represents an integer of 0 to 4, and m represents an integer of 0 to 6) 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinoline compounds represented by and herbicides containing the same as an active ingredient are disclosed. Further, Patent Document 2 discloses the following formula:
[0004]
[0005] (In the formula, ring A 1 , ring B 1 represent a benzene ring or the like, R 6 to R 9 represent a halogen atom, an alkyl group, a hydroxyl group, an alkoxy group or the like, Q is N, N-R 10 (R 10X represents a hydrogen atom, hydroxyl group, alkyl group, etc. 2 Y represents a halogen atom, alkyl group, etc. 2 n represents a halogen atom, alkyl group, etc. 2 represents an integer from 0 to 4, and m 2 (The integers are 0 to 6, and the dotted line indicates a single or double bond.) A 3-(isoquinoline-1-yl)quinoline compound and an insecticide containing it as an active ingredient are disclosed. Furthermore, Patent Document 3 contains the following formula:
[0006]
[0007] (where Y 3 R indicates a halogen atom. 11 , R 12 , and R 13 Each independently represents a lower alkyl group or a lower alkoxy group, R 14 (This indicates a lower alkyl group.) A phenoxypropionic acid ester derivative represented by [formula] and a herbicide containing it as an active ingredient are disclosed. Furthermore, Patent Document 4 contains the following formula:
[0008]
[0009] (wherein, X 4 represents hydrogen atoms, halogen atoms, etc., Y 4 Z represents a halogen atom or alkyl group. 4 R represents an oxygen atom or a sulfur atom. 15 and R 16 (This indicates an alkyl group.) Quinoxaline compounds and insecticides containing them as active ingredients are disclosed. Furthermore, Patent Document 5 contains the following formula:
[0010]
[0011] (wherein, R 17 R represents a hydrogen atom or an alkyl group, etc. 18 (where n3 represents an integer between 2 and 5, and n3 represents an integer between 2 and 5.) A pharmaceutical composition containing the compound shown is disclosed.
[0012] Pamphlet WO2005 / 070917 Pamphlet WO2007 / 011022 Japanese Patent Publication No. Hei 5-148235 Japanese Patent Publication No. Sho 58-92690 US Patent 5578596
[0013] Journal of Medicinal Chemistry, 1981, Vol. 24, (1), pp93-101
[0014] The object of the present invention is to provide a fungicide for agricultural and horticultural use that is effective and safe to use, and a nitrogen-containing heterocyclic compound or a salt thereof that is useful as an active ingredient of the fungicide for agricultural and horticultural use.
[0015] The inventors diligently studied to solve the above problems. As a result, they obtained a nitrogen-containing heterocyclic compound represented by formula (I) and its salt. They found that this nitrogen-containing heterocyclic compound can be used safely and effectively as an active ingredient in fungicides for agriculture and horticulture. The present invention was completed based on these findings and further studies.
[0016] In other words, the present invention encompasses the following aspects. [1] A nitrogen-containing heterocyclic compound represented by formula (I), or a salt thereof.
[0017]
[0018] In formula (I), R is CR 1 R 2 R 3 It represents a group represented by or a cyano group. R 1 ~R 3Each of these independently represents a hydrogen atom, an unsubstituted or substituted C1-8 alkyl group, an unsubstituted or substituted C2-8 alkenyl group, an unsubstituted or substituted C2-8 alkynyl group, an unsubstituted or substituted C3-8 cycloalkyl group, an unsubstituted or substituted C4-8 cycloalkenyl group, an unsubstituted or substituted C6-10 aryl group, an unsubstituted or substituted heterocyclic group, an unsubstituted or substituted C1-8 acyl group, an unsubstituted or substituted (1-imino)C1-8 alkyl group, an unsubstituted or substituted carboxyl group, an unsubstituted or substituted carbamoyl group, an unsubstituted or substituted hydroxyl group, an unsubstituted or substituted amino group, an unsubstituted or substituted mercapto group, a substituted sulfonyl group, a halogeno group, a cyano group, or a nitro group. However, R 1 ~R 3 It is not the case that all of them are hydrogen atoms. Also, R 1 ~R 3 Not all of them are unsubstituted C1-8 alkyl groups. Also, R 1 ~R 3 If one of them is a hydrogen atom, then the remaining two cannot all be unsubstituted C1-8 alkyl groups. Also, R 1 ~R 3 If one of the elements is an unsubstituted C1-8 alkyl group, then the remaining two cannot all be hydrogen atoms. Also, R 1 ~R 3 They may come together to form an unsubstituted or substituted 5- to 8-membered ring, or a group represented by =O, =CR a R b The group represented by (R a and R b Each of these independently represents a hydrogen atom or an unsubstituted or substituted C1-8 alkyl group. Alternatively, they may form a group represented as =N-R' (where R' represents an unsubstituted or substituted hydroxyl group or an unsubstituted or substituted C1-8 alkyl group). X 1Each of these independently represents an unsubstituted or substituted C1-8 alkyl group, an unsubstituted or substituted C2-8 alkenyl group, an unsubstituted or substituted C2-8 alkynyl group, an unsubstituted or substituted hydroxyl group, a halogeno group, a cyano group, or a nitro group. m is X 1 This indicates the number of items and is an integer between 0 and 5. X 2 Each of these independently represents an unsubstituted or substituted C1-8 alkyl group, an unsubstituted or substituted C2-8 alkenyl group, an unsubstituted or substituted C2-8 alkynyl group, an unsubstituted or substituted C3-8 cycloalkyl group, an unsubstituted or substituted C4-8 cycloalkenyl group, an unsubstituted or substituted C6-10 aryl group, an unsubstituted or substituted heterocyclic group, an unsubstituted or substituted C1-8 acyl group, an unsubstituted or substituted (1-imino)C1-8 alkyl group, an unsubstituted or substituted carboxyl group, an unsubstituted or substituted carbamoyl group, an unsubstituted or substituted hydroxyl group, an unsubstituted or substituted amino group, an unsubstituted or substituted mercapto group, a substituted sulfonyl group, a halogeno group, a cyano group, or a nitro group. n is X 2 This indicates the number of items and is an integer between 0 and 3. R 1 ~R 3 One of the following, X 2 It may combine with any one of the following to form an unsubstituted or substituted 5- to 8-membered ring. B represents a carbon atom or a nitrogen atom. D is either unsubstituted or X 1 A 5-7 member hydrocarbon ring substituted with, or unsubstituted or X 1 This shows a 5- to 7-membered heteroring substituted with [the specified component]. A 1 A 2 A 3 , and A 4Each of these independently represents either a carbon atom or a nitrogen atom. However, if B is a carbon atom, then A 1 ~A 4 It is not the case that all of it consists of carbon atoms.
[0019] [2] A nitrogen-containing heterocyclic compound, or a salt thereof, characterized in that formula (I) described in [1] above is represented by formula (II).
[0020]
[0021] (In formula (II), R, 1 , m, X 2 , n, A 1 A 2 A 3 A 4 , and B have the same meanings as in formula (I) described in [1] above.
[0022] [3] A nitrogen-containing heterocyclic compound, or a salt thereof, characterized in that formula (I) described in [1] above is represented by formula (III).
[0023]
[0024] In formula (III), R, 1 , m, X 2 n and B have the same meanings as in formula (I) described in [1] above.
[0025] [4] A nitrogen-containing heterocyclic compound, or a salt thereof, characterized in that formula (I) described in [1] above is represented by formula (IV).
[0026]
[0027] (In formula (IV), R, 1 , m, X 2 , and n have the same meanings as in formula (I) described in [1] above.
[0028] [5] A nitrogen-containing heterocyclic compound, or a salt thereof, characterized in that formula (I) described in [1] above is represented by formula (V).
[0029]
[0030] (In formula (V), R, 1 , m, X 2 , n, and A 1 (These have the same meanings as the respective terms in formula (I) described in [1] above.)
[0031] [6] A nitrogen-containing heterocyclic compound, or a salt thereof, characterized in that formula (I) described in [1] above is represented by formula (VI).
[0032]
[0033] (In formula (VI), R, 1 , m, X 2 , and n have the same meanings as in formula (I) described in [1] above.
[0034] [7] A fungicide for agricultural and horticultural use containing at least one selected from the group consisting of nitrogen-containing heterocyclic compounds and salts thereof as described in any one of the above items [1] to [6] as an active ingredient.
[0035] The nitrogen-containing heterocyclic compounds of the present invention are novel compounds that are useful as active ingredients in fungicides for agriculture and horticulture. The fungicide for agricultural and horticultural use of the present invention has reliable and excellent control effects, does not cause phytotoxicity to plants, and is a safe agent with low toxicity to humans, livestock, and fish, as well as minimal environmental impact.
[0036] The present invention will be described in detail below, divided into two sections: 1) nitrogen-containing heterocyclic compounds and 2) fungicides for agricultural and horticultural use.
[0037] 1) Nitrogen-containing heterocyclic compound The nitrogen-containing heterocyclic compound according to the present invention is a compound represented by formula (I) (hereinafter sometimes referred to as "compound (I)").
[0038]
[0039] The nitrogen-containing heterocyclic compounds according to the present invention include hydrates, various solvates, and crystalline polymorphs. Furthermore, the nitrogen-containing heterocyclic compounds according to the present invention include stereoisomers based on chiral carbon atoms, double bonds, etc., and mixtures thereof.
[0040] First, we will explain the meanings of “unsubstituted” and “having substituents” in formula (I). The term "unsubstituted" means that only the core group is present. When only the name of the core group is given without any mention of "substituted," it means "unsubstituted" unless otherwise specified. On the other hand, the term "substituted" means that one of the hydrogen atoms of the core group is substituted with a group of the same or different structure as the core group. Therefore, a "substituent" is another group bonded to the core group. There may be one substituent or two or more substituents. The two or more substituents may be the same or different. Terms such as "C1-C6" indicate that the parent group has 1 to 6 carbon atoms. This number of carbon atoms does not include the number of carbon atoms in substituents. For example, a butyl group with an ethoxy group as a substituent is classified as a C2 alkoxy C4 alkyl group.
[0041] The "substituents" are chemically acceptable and not particularly limited insofar as they have the effects of the present invention. Groups that can act as "substituents" include halogen atoms such as fluorine, chlorine, bromine, and iodine; C1-6 alkyl groups such as methyl, ethyl, n-propyl, i-propyl, n-butyl, s-butyl, i-butyl, t-butyl, n-pentyl, and n-hexyl groups; and C3-6 cycloalkyl groups such as cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl groups. C2-6 alkenyl groups such as vinyl group, 1-propenyl group, 2-propenyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-methyl-2-propenyl group, 2-methyl-2-propenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-methyl-2-butenyl group, 2-methyl-2-butenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4-hexenyl group, 5-hexenyl group; C3-6 cycloalkenyl groups such as 2-cyclopropenyl group, 2-cyclopentenyl group, 3-cyclohexenyl group; C2-6 alkynyl groups such as ethynyl group, 1-propynyl group, 2-propynyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-methyl-2-propynyl group, 2-methyl-3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, 1-hexynyl group, and 1,1-dimethyl-2-butynyl group;
[0042] C1-6 alkoxy groups such as methoxy group, ethoxy group, n-propoxy group, i-propoxy group, n-butoxy group, s-butoxy group, i-butoxy group, and t-butoxy group; C2-6 alkenyloxy groups such as vinyloxy group, allyloxy group, propenyloxy group, and butenyloxy group; C2-6 alkynyloxy groups such as ethynyloxy group and propargyloxy group; C6-10 aryl groups such as phenyl group and naphthyl group; C6-10 aryloxy groups such as phenoxy group and 1-naphthoxy group; C7-11 aralkyl groups such as benzyl group and phenethyl group; C7-11 aralkyloxy groups such as benzyloxy group and phenethyloxy group; C1-7 acyl groups such as formyl group, acetyl group, propionyl group, benzoyl group, and cyclohexylcarbonyl group; C1-7 acyloxy groups such as formyloxy, acetyloxy, propionyloxy, benzoyloxy, and cyclohexylcarbonyloxy; C1-6 alkoxycarbonyl groups such as methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, i-propoxycarbonyl, n-butoxycarbonyl, and t-butoxycarbonyl; carboxyl groups;
[0043] Hydroxyl groups; Oxo groups; C1-6 haloalkyl groups such as chloromethyl group, chloroethyl group, trifluoromethyl group, 1,2-dichloro-n-propyl group, 1-fluoro-n-butyl group, and perfluoro-n-pentyl group; C2-6 haloalkenyl groups such as 2-chloro-1-propenyl group and 2-fluoro-1-butenyl group; C2-6 haloalkynyl groups such as 4,4-dichloro-1-butynyl group, 4-fluoro-1-pentynyl group, and 5-bromo-2-pentynyl group; C1-6 haloalkoxy groups such as 2-chloro-n-propoxy group and 2,3-dichlorobutoxy group; C2-6 haloalkenyloxy groups such as 2-chloropropenyloxy group and 3-bromobutenyloxy group; C6-10 haloaryl groups such as 4-chlorophenyl group, 4-fluorophenyl group, and 2,4-dichlorophenyl group; C6-10 haloaryloxy groups such as 4-fluorophenyloxy group and 4-chloro-1-naphthoxy group; C1-7 haloacyl groups such as chloroacetyl group, trifluoroacetyl group, trichloroacetyl group, and 4-chlorobenzoyl group;
[0044] Cyano group; Isocyano group; Nitro group; Isocyanato group; Cyanato group; Azide group; Amino group; C1-6 alkylamino groups such as methylamino group, dimethylamino group, and diethylamino group; C6-10 arylamino groups such as anilino group and naphthylamino group; C7-11 aralkylamino groups such as benzylamino group and phenylethylamino group; C1-7 acylamino groups such as formylamino group, acetylamino group, propanoylamino group, butyrylamino group, i-propylcarbonylamino group, and benzoylamino group; C1-6 alkoxycarbonylamino groups such as methoxycarbonylamino group, ethoxycarbonylamino group, n-propoxycarbonylamino group, and i-propoxycarbonylamino group; Carbamoyl group; Substituted carbamoyl groups such as dimethylcarbamoyl group, phenylcarbamoyl group, and N-phenyl-N-methylcarbamoyl group; Imino C1-6 alkyl groups such as iminomethyl group, (1-imino)ethyl group, and (1-imino)-n-propyl group; hydroxyimino C1-6 alkyl groups such as hydroxyiminomethyl group, (1-hydroxyimino)ethyl group, and (1-hydroxyimino)propyl group; C1-6 alkoxyimino C1-6 alkyl groups such as methoxyiminomethyl group and (1-methoxyimino)ethyl group;
[0045] Mercapto group; Isothiocyanato group; Thiocyanato group; C1-6 alkylthio groups such as methylthio, ethylthio, n-propylthio, i-propylthio, n-butylthio, i-butylthio, s-butylthio, and t-butylthio; C2-6 alkenylthio groups such as vinylthio and allylthio; C2-6 alkynylthio groups such as ethynylthio and propargylthio; C6-10 arylthio groups such as phenylthio and naphthylthio; heteroarylthio groups such as thiazolylthio and pyridylthio; C7-11 aralkylthio groups such as benzylthio and phenethylthio; (C1-6 alkylthio)carbonyl groups such as (methylthio)carbonyl group, (ethylthio)carbonyl group, (n-propylthio)carbonyl group, (i-propylthio)carbonyl group, (n-butylthio)carbonyl group, (i-butylthio)carbonyl group, (s-butylthio)carbonyl group, (t-butylthio)carbonyl group, etc.
[0046] C1-6 alkyl sulfinyl groups such as methyl sulfinyl group, ethyl sulfinyl group, and t-butyl sulfinyl group; C2-6 alkenyl sulfinyl groups such as allyl sulfinyl group; C2-6 alkynyl sulfinyl groups such as propargyl sulfinyl group; C6-10 aryl sulfinyl groups such as phenyl sulfinyl group; heteroaryl sulfinyl groups such as thiazolyl sulfinyl group and pyridyl sulfinyl group; C7-11 aralkyl sulfinyl groups such as benzyl sulfinyl group and phenethyl sulfinyl group; C1-6 alkyl sulfonyl groups such as methyl sulfonyl group, ethyl sulfonyl group, and t-butyl sulfonyl group; C2-6 alkenyl sulfonyl groups such as allyl sulfonyl group; C2-6 alkynyl sulfonyl groups such as propargyl sulfonyl group; C6-10 aryl sulfonyl groups such as phenyl sulfonyl group; heteroaryl sulfonyl groups such as thiazolyl sulfonyl group and pyridyl sulfonyl group; C7-11 aralkylsulfonyl groups such as benzylsulfonyl groups and phenethylsulfonyl groups;
[0047] Examples include five-membered heteroaryl groups such as pyrrolyl group, furyl group, thienyl group, imidazolyl group, pyrazolyl group, oxazolyl group, isoxazolyl group, thiazolyl group, isothiazolyl group, triazolyl group, oxadiazolyl group, thiadiazolyl group, and tetrazolyl group; six-membered heteroaryl groups such as pyridyl group, pyrazinyl group, pyrimidinyl group, pyridanidyl group, and triazinyl group; saturated heterocyclic groups such as aziridinyl group, epoxy group, pyrrolidinyl group, tetrahydrofuranyl group, piperidyl group, piperazinyl group, and morpholinyl group; triC1-6 alkylsilyl groups such as trimethylsilyl group, triethylsilyl group, and t-butyldimethylsilyl group; and triphenylsilyl group.
[0048] Furthermore, these "substituents" may have other "substituents" within them. For example, a butyl group as a substituent may have an ethoxy group as another substituent, i.e., an ethoxybutyl group.
[0049] [R] R stands for CR 1 R 2 R 3 It represents a group represented by or a cyano group. R 1 ~R 3 Each of these independently represents a hydrogen atom, an unsubstituted or substituted C1-8 alkyl group, an unsubstituted or substituted C2-8 alkenyl group, an unsubstituted or substituted C2-8 alkynyl group, an unsubstituted or substituted C3-8 cycloalkyl group, an unsubstituted or substituted C4-8 cycloalkenyl group, an unsubstituted or substituted C6-10 aryl group, an unsubstituted or substituted heterocyclic group, an unsubstituted or substituted C1-8 acyl group, an unsubstituted or substituted (1-imino)C1-8 alkyl group, an unsubstituted or substituted carboxyl group, an unsubstituted or substituted carbamoyl group, an unsubstituted or substituted hydroxyl group, an unsubstituted or substituted amino group, an unsubstituted or substituted mercapto group, a substituted sulfonyl group, a halogeno group, a cyano group, or a nitro group. However, R1 to R 3 are not all hydrogen atoms. Also, R 1 to R 3 are not all unsubstituted C1-8 alkyl groups. Also, R 1 to R 3 if any one of them is a hydrogen atom, the remaining two are not all unsubstituted C1-8 alkyl groups. Also, R 1 to R 3 if any one of them is an unsubstituted C1-8 alkyl group, the remaining two are not all hydrogen atoms.
[0050] The "C1-8 alkyl group" is a saturated hydrocarbon group composed of 1 to 8 carbon atoms. The C1-8 alkyl group may be linear or branched. Examples of the C1-8 alkyl group include methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group, n-heptyl group, n-octyl group, i-propyl group, i-butyl group, s-butyl group, t-butyl group, i-pentyl group, neopentyl group, 2-methylbutyl group, 2,2-dimethylpropyl group, i-hexyl group, etc. Among these, the C1-6 alkyl group is preferred.
[0051] Examples of the "substituted C1-8 alkyl group" include cycloalkylalkyl groups such as cyclopropylmethyl group, 2-cyclopropylethyl group, cyclopentylmethyl group, 2-cyclohexylethyl group, preferably C3-6 cycloalkyl C1-6 alkyl group; cycloalkenylalkyl groups such as cyclopentenylmethyl group, 3-cyclopentenylmethyl group, 3-cyclohexenylmethyl group, 2-(3-cyclohexenyl)ethyl group, preferably C4-6 cycloalkenyl C1-6 alkyl group; Haloalkyl groups such as fluoromethyl group, chloromethyl group, bromomethyl group, difluoromethyl group, dichloromethyl group, dibromomethyl group, trifluoromethyl group, trichloromethyl group, tribromomethyl group, 2,2,2-tolufluoroethyl group, 2,2,2-trichloroethyl group, pentafluoroethyl group, 4-fluorobutyl group, 4-chlorobutyl group, 3,3,3-trifluoropropyl group, 2,2,2-trifluoro-1-trifluoromethylethyl group, perfluorohexyl group, perchlorohexyl group, perfluorooctyl group, perchlorooctyl group, 2,4,6-trichlorohexyl group, perfluorodecyl group, 2,2,4,4,6,6-hexachlorooctyl group, preferably C1 to C6 haloalkyl groups; Ararylalkyl groups such as benzyl group, phenethyl group, 3-phenylpropyl group, 1-naphthylmethyl group, and 2-naphthylmethyl group, preferably C6-10 arylC1-6 alkyl groups;
[0052] 2-pyridylmethyl group, 3-pyridylmethyl group, 4-pyridylmethyl group, 2-(2-pyridyl)ethyl group, 2-(3-pyridyl)ethyl group, 2-(4-pyridyl)ethyl group, 3-(2-pyridyl)propyl group, 3-(3-pyridyl)propyl group, 3-(4-pyridyl)propyl group, 2-pyradinylmethyl group, 3-pyradinylmethyl group, 2-(2-pyradinyl)ethyl group, 2-(3-pyradinyl)ethyl group, 3-(2-pyradinyl)propyl group, 3-(3-pyradinyl)propyl Heteroarylalkyl groups such as pyr group, 2-pyrimidylmethyl group, 4-pyrimidylmethyl group, 2-(2-pyrimidyl)ethyl group, 2-(4-pyrimidyl)ethyl group, 3-(2-pyrimidyl)propyl group, 3-(4-pyrimidyl)propyl group, 2-furylmethyl group, 3-furylmethyl group, 2-(2-furyl)ethyl group, 2-(3-furyl)ethyl group, 3-(2-furyl)propyl group, 3-(3-furyl)propyl group, preferably 5-6 member heteroaryl C1-6 alkyl groups; Hydroxyalkyl groups such as hydroxymethyl group, 1-hydroxyethyl group, 2-hydroxyethyl group, 1-hydroxypropyl group, 3-hydroxypropyl group, 1-hydroxy-1-methylethyl group, 2-hydroxy-1,1-dimethylethyl group, 2-hydroxy-1,1-dimethylpropyl group, and 2-hydroxy-2-methylpropyl group, preferably hydroxy C1 to 6 alkyl groups; Alkoxyalkyl groups such as methoxymethyl group, ethoxymethyl group, 2-methoxyethyl group, 2-ethoxyethyl group, methoxy-n-propyl group, n-propoxymethyl group, i-propoxyethyl group, s-butoxymethyl group, t-butoxyethyl group, 2,2-dimethoxyethyl group, and 2,2-dimethoxy-1,1-dimethylethyl group, preferably C1-6 alkoxyC1-6 alkyl groups; Acyloxyalkyl groups such as formyloxymethyl group, acetoxymethyl group, 2-acetoxyethyl group, propionyloxymethyl group, and propionyloxyethyl group, preferably C1-7 acyloxyC1-6 alkyl groups; Trialkylsilyloxyalkyl groups such as trimethylsilyloxymethyl group and t-butyldimethylsilyloxymethyl group, preferably triC1-6 alkylsilyloxyC1-6 alkyl groups; Arylsulfonyloxyalkyl groups such as tosyloxymethyl group and 2-tosyloxy-1,1-dimethylethyl group, preferably C1-6 alkyl-substituted C6-10 arylsulfonyloxy C1-6 alkyl groups; Cyanoalkyl groups such as cyanomethyl group, 2-cyanoethyl group, and 1-cyano-1-methylethyl group, preferably cyanoC1 to 6 alkyl groups; Acylalkyl groups such as formylmethyl group, 2-formylethyl group, 3-formylpropyl group, 1-formyl-1-methylethyl group, 2-formyl-1,1-dimethylethyl group, acetylmethyl group, 2-acetylethyl group, 3-acetylpropyl group, 1-acetyl-1-methylethyl group, and 2-acetyl-1,1-dimethylethyl group, preferably C1-7 acylC1-6 alkyl groups; 2-hydroxyiminoalkyl groups such as 2-hydroxyiminoethyl group, 2-hydroxyimino-1-methylethyl group, 2-hydroxy-1,1-dimethylethyl group, and 2-hydroxyiminopropyl group, preferably 2-hydroxyimino C2 to 6 alkyl groups; Acylalkyl groups such as acetylmethyl group, 2-acetylethyl group, 3-acetylpropyl group, 1-acetyl-1-methylethyl group, and 2-acetyl-1,1-dimethylethyl group, preferably C1-7 acylC1-6 alkyl groups; Carboxyalkyl groups such as carboxymethyl group, 2-carboxyethyl group, 3-carboxypropyl group, 1-carboxy-1-methylethyl group, and 2-carboxy-1,1-dimethylethyl group, preferably carboxyC1 to C6 alkyl groups; Alkoxycarbonyl alkyl groups such as methoxycarbonylmethyl group, 2-methoxycarbonylethyl group, 3-methoxycarbonylpropyl group, 1-methoxycarbonyl-1-methylethyl group, and 2-methoxycarbonyl-1,1-dimethylethyl group, preferably C1-6 alkoxycarbonyl C1-6 alkyl groups; Examples include azidoalkyl groups such as azidomethyl group, 2-azidoethyl group, and 1-azido-1-methylethyl group, preferably azido C1 to 6 alkyl groups.
[0053] The "C2-8 alkenyl group" is an unsaturated hydrocarbon group composed of 2 to 8 carbon atoms, each having at least one carbon-carbon double bond. The C2-8 alkenyl group may be a straight chain or a branched chain. Examples of C2-8 alkenyl groups include vinyl group, 1-propenyl group, isopronpenyl group, allyl group, 1-butenyl group, 2-butenyl group, 3-butenyl group, 1-pentenyl group, 2-pentenyl group, 3-pentenyl group, 4-pentenyl group, 1-hexenyl group, 2-hexenyl group, 3-hexenyl group, 4-hexenyl group, 5-hexenyl group, 1-heptenyl group, 6-heptenyl group, 1-octenyl group, 7-octenyl group, 1-methyl-allyl group, 2-methyl-allyl group, 1-methyl-2-butenyl group, and 2-methyl-2-butenyl group. Of these, C2-6 alkenyl groups are preferred.
[0054] The "substituted C2-8 alkenyl group" may be a haloalkenyl group such as 3-chloro-2-propenyl group, 4-chloro-2-butenyl group, 4,4-dichloro-3-butenyl group, 4,4-difluoro-3-butenyl group, 3,3-dichloro-2-propenyl group, 2,3-dichloro-2-propenyl group, 3,3-difluoro-2-propenyl group, or 2,4,6-trichloro-2-hexenyl group, preferably a C2-6 haloalkenyl group; Examples include hydroxyalkenyl groups such as 3-hydroxy-1-propenyl group, 4-hydroxy-1-butenyl group, 1-hydroxyallyl group, and 1-hydroxy-2-methylallyl group, preferably hydroxy C2 to 6 alkenyl groups.
[0055] The "C2-8 alkynyl group" is an unsaturated hydrocarbon group composed of 2 to 8 carbon atoms having at least one carbon-carbon triple bond. The C2-8 alkynyl group may be a straight chain or a branched chain. Examples of C2-8 alkynyl groups include ethynyl group, 1-propynyl group, propargyl group, 1-butynyl group, 2-butynyl group, 3-butynyl group, 1-pentynyl group, 2-pentynyl group, 3-pentynyl group, 4-pentynyl group, 1-hexynyl group, 1-methyl-2-propynyl group, 2-methyl-3-butynyl group, 1-methyl-2-butynyl group, 2-methyl-3-pentynyl group, and 1,1-dimethyl-2-butynyl group. Of these, the C2-6 alkynyl group is preferred.
[0056] Examples of "substituted C2-8 alkynyl groups" include haloalkynyl groups such as 3-chloro-1-propynyl group, 3-chloro-1-butynyl group, 3-bromo-1-butynyl group, 3-bromo-2-propynyl group, 3-iodo-2-propynyl group, 3-bromo-1-hexynyl group, 4,4,6,6-tetrafluoro-1-dodecynyl group, 5,5-dichloro-2-methyl-3-pentynyl group, and 4-chloro-1,1-dimethyl-2-butynyl group, preferably C2-6 haloalkynyl groups.
[0057] A "C3-8 cycloalkyl group" is an alkyl group composed of 3 to 8 carbon atoms having a cyclic portion. Examples of C3-8 cycloalkyl groups include cyclopropyl group, cyclobutyl group, cyclopentyl group, cyclohexyl group, cycloheptyl group, and cyclooctyl group. Of these, C3-6 cycloalkyl groups are preferred.
[0058] Examples of "substituted C3-8 cycloalkyl groups" include alkyl-substituted cycloalkyl groups such as 2,3,3-trimethylcyclobutyl group, 4,4,6,6-tetramethylcyclohexyl group, and 1,3-dibutylcyclohexyl group, preferably C3-6 cycloalkyl groups in which 1 to 3 C1-6 alkyl groups are substituted.
[0059] A "C4-8 cycloalkenyl group" is an alkenyl group composed of 4 to 8 carbon atoms having a cyclic portion. Examples of C4-8 cycloalkenyl groups include 1-cyclobutenyl group, 1-cyclopentenyl group, 3-cyclopentenyl group, 1-cyclohexenyl group, 3-cyclohexenyl group, 3-cycloheptenyl group, and 4-cyclooctenyl group.
[0060] Examples of "substituted C4-8 cycloalkenyl groups" include alkyl-substituted cycloalkenyl groups such as 2-methyl-3-cyclohexenyl group and 3,4-dimethyl-3-cyclohexenyl group, preferably C4-6 cycloalkenyl groups substituted with 1 to 3 C1-6 alkyl groups.
[0061] The "C6-10 aryl group" is a monocyclic or polycyclic aryl group having 6 to 10 carbon atoms. In the case of a polycyclic aryl group, at least one ring is an aromatic ring, and the remaining rings may be saturated alicyclic, unsaturated alicyclic, or aromatic rings. Examples of C6-10 aryl groups include phenyl group, naphthyl group, azulenyl group, indenyl group, indanyl group, and tetralinyl group. Of these, the phenyl group is preferred. Examples of "substituted C6-10 aryl groups" include alkyl-substituted aryl groups, halogeno-substituted aryl groups, alkoxy-substituted aryl groups, and preferably C1-6 alkyl-substituted C6-10 aryl groups, halogeno-substituted C6-10 aryl groups, and C1-6 alkoxy-substituted aryl groups.
[0062] A "heterocyclic group" contains one to four heteroatoms selected from nitrogen, oxygen, and sulfur atoms as constituent atoms of the ring. The heterocyclic group may be monocyclic or polycyclic. Examples of heterocyclic groups include five-membered heteroaryl groups, six-membered heteroaryl groups, fused heteroaryl groups, saturated heterocyclic groups, and partially unsaturated heterocyclic groups.
[0063] Examples of five-membered heteroaryl groups include pyrrolyl groups such as pyrrole-1-yl, pyrrole-2-yl, and pyrrole-3-yl; furyl groups such as furan-2-yl and furan-3-yl; thienyl groups such as thiophene-2-yl and thiophene-3-yl; imidazolyl groups such as imidazole-1-yl, imidazole-2-yl, imidazole-4-yl, and imidazole-5-yl; pyrazolyl groups such as pyrazole-1-yl, pyrazole-3-yl, pyrazole-4-yl, and pyrazole-5-yl; oxazolyl groups such as oxazole-2-yl, oxazole-4-yl, and oxazole-5-yl; isoxazolyl groups such as isoxazole-3-yl, isoxazole-4-yl, and isoxazole-5-yl; Thiazolyl groups such as thiazole-2-yl, thiazole-4-yl, and thiazole-5-yl; isothiazolyl groups such as isothiazole-3-yl, isothiazole-4-yl, and isothiazole-5-yl; triazolyl groups such as 1,2,3-triazole-1-yl, 1,2,3-triazole-4-yl, 1,2,3-triazole-5-yl, 1,2,4-triazole-1-yl, 1,2,4-triazole-3-yl, and 1,2,4-triazole-5-yl; oxadiazolyl groups such as 1,2,4-oxadiazole-3-yl, 1,2,4-oxadiazole-5-yl, and 1,3,4-oxadiazole-2-yl; Examples include thiadiazolyl groups such as 1,2,4-thiadiazole-3-yl group, 1,2,4-thiadiazole-5-yl group, and 1,3,4-thiadiazole-2-yl group; and tetrazolyl groups such as tetrazole-1-yl group and tetrazole-2-yl group.
[0064] Examples of six-membered heteroaryl groups include pyridyl groups such as pyridine-2-yl, pyridine-3-yl, and pyridine-4-yl; pyrazinyl groups such as pyrazine-2-yl and pyrazine-3-yl; pyrimidinyl groups such as pyrimidine-2-yl, pyrimidine-4-yl, and pyrimidine-5-yl; pyridazinyl groups such as pyridazine-3-yl and pyridazine-4-yl; triazinyl groups; and the like.
[0065] Examples of condensed heteroaryl groups include indole-1-yl group, indole-2-yl group, indole-3-yl group, indole-4-yl group, indole-5-yl group, indole-6-yl group, indole-7-yl group; benzofuran-2-yl group, benzofuran-3-yl group, benzofuran-4-yl group, benzofuran-5-yl group, benzofuran-6-yl group, benzofuran-7-yl group; benzothiophene-2-yl group, benzothiophene-3-yl group, benzothiophene-4-yl group, benzothiophene-5-yl group, benzothiophene-6-yl group, benzothiophene-7-yl group; Examples include benzimidazole-1-yl group, benzimidazole-2-yl group, benzimidazole-4-yl group, benzimidazole-5-yl group, benzoxazole-2-yl group, benzoxazole-4-yl group, benzoxazole-5-yl group, benzothiazole-2-yl group, benzothiazole-4-yl group, benzothiazole-5-yl group; quinoline-2-yl group, quinoline-3-yl group, quinoline-4-yl group, quinoline-5-yl group, quinoline-6-yl group, quinoline-7-yl group, quinoline-8-yl group; and so on.
[0066] Other heterocyclic groups include: three-membered saturated heterocyclic rings such as aziridine-1-yl group, aziridine-2-yl group, and oxyranyl group; five-membered saturated heterocyclic rings such as pyrrolidine-1-yl group, pyrrolidine-2-yl group, pyrrolidine-3-yl group, tetrahydrofuran-2-yl group, tetrahydrofuran-3-yl group, and [1,3]dioxyran-2-yl group; six-membered saturated heterocyclic rings such as piperidine-1-yl group, piperidine-2-yl group, piperidine-3-yl group, piperidine-4-yl group, piperazine-1-yl group, piperazine-2-yl group, morpholine-2-yl group, morpholine-3-yl group, and morpholine-4-yl group; Examples include 1,3-benzodioxol-4-yl group, 1,3-benzodioxol-5-yl group, 1,4-benzodioxan-5-yl group, 1,4-benzodioxan-6-yl group, 3,4-dihydro-2H-1,5-benzodioxepin-6-yl group, 3,4-dihydro-2H-1,5-benzodioxepin-7-yl group, 2,3-dihydrobenzofuran-4-yl group, 2,3-dihydrobenzofuran-5-yl group, 2,3-dihydrobenzofuran-6-yl group, and 2,3-dihydrobenzofuran-7-yl group.
[0067] Examples of "substituted heterocyclic groups" include 4-chloro-2-pyridinyl group, 3-chloro-2-pyradinyl group, 4-methyl-2-pyridinyl group, 5-trifluoromethyl-2-pyridinyl group, and 3-methyl-2-quinolyl group.
[0068] A "C1-8 acyl group" is a group in which a hydrogen atom, a C1-6 alkyl group, a C2-6 alkenyl group, a C2-6 alkynyl group, a C6-7 aryl group, or a 5-7 membered heterocyclic group is bonded to a carbonyl group. Examples of C1-8 acyl groups include formyl group; alkylcarbonyl groups such as acetyl group, propionyl group, n-propylcarbonyl group, n-butylcarbonyl group, pentanoyl group, valeryl group, octanoyl group, i-propylcarbonyl group, i-butylcarbonyl group, pivaloyl group, and isovaleryl group, preferably C1-6 alkylcarbonyl groups; alkenylcarbonyl groups such as acryloyl group and methacryloyl group, preferably C2-6 alkenylcarbonyl groups; alkynylcarbonyl groups such as propioloyl group, preferably C2-6 alkynylcarbonyl groups; C6-C7 arylcarbonyl groups such as benzoyl group; and heterocyclic carbonyl groups such as 2-pyridylcarbonyl group and thienylcarbonyl group.
[0069] Examples of "substituted C1-8 acyl groups" include haloacyl groups such as monofluoroacetyl, monochloroacetyl, monobromoacetyl, difluoroacetyl, dichloroacetyl, dibromoacetyl, trifluoroacetyl, trichloroacetyl, tribromoacetyl, 3,3,3-trifluoropropionyl, 3,3,3-trichloropropionyl, and 2,2,3,3,3-pentafluoropropionyl, preferably C1-8 haloacyl groups.
[0070] "(1-imino)C1-8 alkyl group" is an iminomethyl group, or a group in which a C1-7 alkyl group is bonded to an iminomethyl group. Examples of (1-imino)C1-8 alkyl groups include iminomethyl group, (1-imino)ethyl group, (1-imino)propyl group, (1-imino)butyl group, (1-imino)pentyl group, (1-imino)hexyl group, and (1-imino)heptyl group. Of these, (1-imino)C1-6 alkyl groups are preferred. Examples of "substituted (1-imino)C1-8 alkyl groups" include (1-hydroxyimino) alkyl groups such as hydroxyiminomethyl group, (1-hydroxyimino)ethyl group, (1-hydroxyimino)propyl group, and (1-hydroxyimino)butyl group, preferably (1-hydroxyimino)C1-6 alkyl groups; and (1-alkoxyimino) alkyl groups such as methoxyiminomethyl group, (1-ethoxyimino)methyl group, (1-methoxyimino)ethyl group, (1-t-butoxyimino)ethyl group, and (1-ethoxyimino)ethyl group, preferably (1-(C1-6 alkoxy)imino)C1-6 alkyl groups.
[0071] A "substituted carboxyl group" is a group in which a C1-6 alkyl group, a C2-6 alkenyl group, a C2-6 alkynyl group, a C6-10 aryl group, a C6-10 arylC1-6 alkyl group, or a 5-6 membered heterocyclic group is bonded to a carbonyl group.
[0072] The "substituted carboxyl group" may be an alkoxycarbonyl group such as a methoxycarbonyl group, ethoxycarbonyl group, n-propoxycarbonyl group, i-propoxycarbonyl group, n-butoxycarbonyl group, i-butoxycarbonyl group, t-butoxycarbonyl group, n-pentyloxycarbonyl group, or n-hexyloxycarbonyl group, preferably a C1-6 alkoxycarbonyl group; Alkenyloxycarbonyl groups such as vinyloxycarbonyl groups and allyloxycarbonyl groups, preferably C2-6 alkenyloxycarbonyl groups; Alkynyloxycarbonyl groups such as ethynyloxycarbonyl groups and propargyloxycarbonyl groups, preferably C2-6 alkynyloxycarbonyl groups; Aryloxycarbonyl groups such as phenoxycarbonyl groups and naphthoxycarbonyl groups, preferably C6-10 aryloxycarbonyl groups; Examples include aralkyloxycarbonyl groups such as benzyloxycarbonyl groups, preferably C6-10 arylC1-6 alkoxycarbonyl groups; and so on.
[0073] A "substituted carbamoyl group" is a group in which a C1-6 alkyl group, a C2-6 alkenyl group, a C2-6 alkynyl group, a C6-10 aryl group, a C6-10 arylC1-6 alkyl group, or a 5-6 membered heterocyclic group is bonded to a carbamoyl group.
[0074] Examples of "substituted carbamoyl groups" include monoalkylcarbamoyl groups or dialkylcarbamoyl groups such as methylcarbamoyl group, ethylcarbamoyl group, dimethylcarbamoyl group, and diethylcarbamoyl group, preferably monoC1-6 alkylcarbamoyl groups or diC1-6 alkylcarbamoyl groups; monoarylcarbamoyl groups such as phenylcarbamoyl group and 4-methylphenylcarbamoyl group, preferably monoC6-10 arylcarbamoyl groups; and the like.
[0075] "Hydroxy group having substituents" may be an alkoxy group such as a methoxy group, ethoxy group, n-propoxy group, n-butoxy group, n-pentyloxy group, n-hexyloxy group, decyloxy group, dodecyloxy group, lauryloxy group, i-propoxy group, i-butoxy group, s-butoxy group, t-butoxy group, 1-ethylpropoxy group, i-hexyloxy group, 4-methylpentoxy group, 3-methylpentoxy group, 2-methylpentoxy group, 1-methylpentoxy group, 3,3-dimethylbutoxy group, 2,2-dimethylbutoxy group, 1,1-dimethylbutoxy group, 1,2-dimethylbutoxy group, 1,3-dimethylbutoxy group, 2,3-dimethylbutoxy group, 1-ethylbutoxy group, 2-ethylbutoxy group, preferably a C1- to C6 alkoxy group;
[0076] Cycloalkylalkoxy groups such as cyclopropylmethyloxy group and 2-cyclopentylethyloxy group, preferably C3-8 cycloalkylC1-6 alkoxy groups; aralkyloxy groups such as benzyloxy group, preferably C6-10 arylC1-6 alkoxy groups; haloalkoxy groups such as chloromethoxy group, dichloromethoxy group, trichloromethoxy group, trifluoromethoxy group, 1-fluoroethoxy group, 1,1-difluoroethoxy group, 2,2,2-trifluoroethoxy group, and pentafluoroethoxy group, preferably C1-6 haloalkoxy groups; Alkenyloxy groups such as vinyloxy group, 1-propenyloxy group, allyloxy group, 1-butenyloxy group, 2-butenyloxy group, 3-butenyloxy group, 1-pentenyloxy group, 2-pentenyloxy group, 3-pentenyloxy group, 4-pentenyloxy group, 1-hexenyloxy group, 2-hexenyloxy group, 3-hexenyloxy group, 4-hexenyloxy group, 5-hexenyloxy group, 1-methyl-2-propenyloxy group, 2-methyl-2-propenyloxy group, 1-methyl-2-butenyloxy group, 2-methyl-2-butenyloxy group, preferably C2-6 alkenyloxy groups;
[0077] Alkynyloxy groups such as ethynyloxy group, propynyloxy group, propargyloxy group, 1-butynyloxy group, 2-butynyloxy group, 3-butynyloxy group, 1-pentynyloxy group, 2-pentynyloxy group, 3-pentynyloxy group, 4-pentynyloxy group, 1-hexynyloxy group, 1-methyl-2-propynyloxy group, 2-methyl-3-butynyloxy group, 1-methyl-2-butynyloxy group, 2-methyl-3-pentynyloxy group, 1,1-dimethyl-2-butynyloxy group, preferably C2-6 alkynyloxy groups; Cycloalkyloxy groups such as cyclopropyloxy group, cyclobutyloxy group, cyclopentyloxy group, cyclohexyloxy group, cycloheptyloxy group, cyclooctyloxy group, 2-methylcyclopropyloxy group, 2-ethylcyclopropyloxy group, 2,3,3-trimethylcyclobutyloxy group, 2-methylcyclopentyloxy group, 2-ethylcyclohexyloxy group, 2-ethylcyclooctyloxy group, 4,4,6,6-tetramethylcyclohexyloxy group, 1,3-dibutylcyclohexyloxy group, preferably C3-6 cycloalkyloxy groups; aryloxy groups such as phenyloxy group, naphthyloxy group, azulenyloxy group, indenyloxy group, indanyloxy group, tetralinyloxy group, preferably C6-10 aryloxy groups; Arylalkyloxy groups such as benzyloxy, phenethyloxy, and 2-naphthylmethyloxy groups, preferably C6-10 arylC1-6 alkyloxy groups; Acyloxy groups such as acetyloxy group, propionyloxy group, n-propylcarbonyloxy group, i-propylcarbonyloxy group, n-butylcarbonyloxy group, i-butylcarbonyloxy group, pentanoyloxy group, pivaloyloxy group, preferably C1-7 acyloxy groups; Alkoxycarbonylalkyloxy groups such as methoxycarbonylmethyloxy group and 1-methoxycarbonyl-1-methylethyloxy group, preferably C1-6 alkoxycarbonyl C1-6 alkoxy groups; Trialkylsilyloxy groups such as trimethylsilyloxy group and t-butyldimethylsilyloxy group, preferably triC1-6 alkylsilyloxy groups; These are some examples.
[0078] Examples of "substituted amino groups" include alkylamino groups such as methylamino group, ethylamino group, n-propylamino group, n-butylamino group, dimethylamino group, and diethylamino group, preferably mono-C1 to 6 alkylamino groups or di-C1 to 6 alkylamino groups; mono-C1 to 6 alkylideneamino groups such as methylideneamino group and ethylideneamino group; monoarylamino groups such as phenylamino group and 4-methylphenylamino group, preferably mono-C6 to 10 arylamino groups; diarylamino groups such as di-1-naphthylamino group, preferably di-C6 to 10 arylamino groups; aralkylamino groups such as benzylamino group, preferably C6 to 10 arylC1 to 6 alkylamino groups; acylamino groups such as acetylamino group, trifluoroacetylamino group, and benzoylamino group, preferably C1 to 6 acylamino groups; alkoxycarbonylamino groups such as methoxycarbonylamino group and t-butoxycarbonylamino group, preferably C1 to 6 alkoxycarbonylamino groups; and the like.
[0079] Examples of "substituted mercapto groups" include alkylthio groups such as methylthio groups and ethylthio groups, preferably C1-6 alkylthio groups; arylthio groups such as phenylthio groups and 4-methylphenylthio groups, preferably C6-10 arylthio groups; acylthio groups such as acetylthio groups and benzoylthio groups, preferably C1-6 acylthio groups; and the like.
[0080] Examples of the "sulfonyl group having a substituent" include alkylsulfonyl groups such as methylsulfonyl group, ethylsulfonyl group, n-propylsulfonyl group, i-propylsulfonyl group, n-butylsulfonyl group, i-butylsulfonyl group, s-butylsulfonyl group, t-butylsulfonyl group, n-pentylsulfonyl group, i-pentylsulfonyl group, neopentylsulfonyl group, 1-ethylpropylsulfonyl group, n-hexylsulfonyl group, i-hexylsulfonyl group, preferably C1-6 alkylsulfonyl group; haloalkylsulfonyl groups such as trifluoromethylsulfonyl group, preferably C1-6 haloalkylsulfonyl group; arylsulfonyl groups such as phenylsulfonyl group, 4-methylphenylsulfonyl group, preferably C6-10 arylsulfonyl group; sulfo group; alkoxysulfonyl groups such as methoxysulfonyl group, ethoxysulfonyl group, preferably C1-6 alkoxysulfonyl group; sulfamoyl group; sulfamoyl groups such as N-methylsulfamoyl group, N-ethylsulfamoyl group, N,N-dimethylsulfamoyl group, N,N-diethylsulfamoyl group, preferably mono C1-6 alkylsulfamoyl group or di C1-6 alkylsulfamoyl group; monoarylsulfamoyl groups such as phenylsulfamoyl group, 4-methylphenylsulfamoyl group, preferably mono C6-10 arylsulfamoyl group; and the like.
[0081] Examples of the "halogeno group" include fluorine atom, chlorine atom, bromine atom, iodine atom and the like.
[0082] R 1 and R 2 may together form an unsubstituted or substituted 5- to 8-membered ring, or may form a group represented by =O, a group represented by =CR a R b or a group represented by =N-R'. Here, R a represents a hydrogen atom or an unsubstituted or substituted C1-8 alkyl group. R bR' represents a hydrogen atom or an unsubstituted or substituted C1-8 alkyl group. R' represents an unsubstituted or substituted hydroxyl group or an unsubstituted or substituted C1-8 alkyl group. R a , R b , and in R', the unsubstituted or substituted C1-8 alkyl groups are R 1 ~R 3 In this context, the same "C1-8 alkyl groups" as exemplified can be cited. In R', the substituted hydroxyl group is the same as in R 1 ~R 3 In this context, the same "hydroxyl group having a substituent" as exemplified can be cited.
[0083] R 1 and R 2 Examples of unsubstituted or substituted 5- to 8-membered rings that can be formed together include aliphatic hydrocarbon rings such as cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, and cyclooctane rings, preferably C3- to 8-cycloalkane rings; and unsaturated heterocycles such as oxirane, [1,3]dioxirane, dihydro-2H-pyran, dihydro-2H-thiopyran, and tetrahydropyridine rings, preferably oxygen-containing 3- to 5-membered unsaturated heterocycles.
[0084] [X 1 ,m] X 1 Each of these independently represents an unsubstituted or substituted C1-8 alkyl group, an unsubstituted or substituted C2-8 alkenyl group, an unsubstituted or substituted C2-8 alkynyl group, an unsubstituted or substituted hydroxyl group, a halogeno group, a cyano group, or a nitro group. m is X 1 This indicates the number of items and is an integer between 0 and 5. X 1 These groups indicated by are R 1 ~R 3 The same examples given as the basis for the indication can be cited. X 1Preferably, these include C1-6 alkyl groups, C1-6 haloalkyl groups, C2-6 alkenyl groups, C3-8 cycloalkyl groups, hydroxyl groups, C1-6 alkoxy groups, or halogeno groups.
[0085] [X 2 ,n) X 2 Each of these independently represents an unsubstituted or substituted C1-8 alkyl group, an unsubstituted or substituted C2-8 alkenyl group, an unsubstituted or substituted C2-8 alkynyl group, an unsubstituted or substituted C3-8 cycloalkyl group, an unsubstituted or substituted C4-8 cycloalkenyl group, an unsubstituted or substituted C6-10 aryl group, an unsubstituted or substituted heterocyclic group, an unsubstituted or substituted C1-8 acyl group, an unsubstituted or substituted (1-imino)C1-8 alkyl group, an unsubstituted or substituted carboxyl group, an unsubstituted or substituted carbamoyl group, an unsubstituted or substituted hydroxyl group, an unsubstituted or substituted amino group, an unsubstituted or substituted mercapto group, a substituted sulfonyl group, a halogeno group, a cyano group, or a nitro group. n is X 2 This indicates the number of items and is an integer between 0 and 3. X 2 These groups indicated by are R 1 ~R 3 The same examples given as the basis for the indication can be cited. X 2 Preferably, these include C1-6 alkyl groups, C1-6 haloalkyl groups, C6-10 arylC1-6 alkyl groups, C3-8 cycloalkyl groups, C6-10 aryl groups, C1-7 acyl groups, C1-6 alkoxycarbonyl groups, C1-6 alkoxy groups, amino groups, monoC1-6 alkylamino groups, diC1-6 alkylamino groups, C1-6 alkoxycarbonylamino groups, C1-6 alkylthio groups, C1-6 alkylsulfonyl groups, halogeno groups, cyano groups, or nitro groups.
[0086] Here, R 1 ~R 3 One of the following, X2 It may combine with any one of the following to form an unsubstituted or substituted 5- to 8-membered ring. Examples of 5- to 8-membered rings include aromatic hydrocarbon rings such as benzene rings; and C5- to 8-cycloalkene rings such as cyclopentene rings, cyclopentadiene rings, cyclohexene rings, cycloheptene rings, and cyclooctene rings.
[0087] [B, D] B represents a carbon atom or a nitrogen atom. That is, it constitutes a pyridine ring or a pyrazine ring fused with "D". D is either unsubstituted or X 1 A 5-7 member hydrocarbon ring substituted with, or unsubstituted or X 1 This shows a 5- to 7-membered heteroring substituted with [the specified component]. Examples of 5-7 membered hydrocarbon rings include aromatic hydrocarbon rings such as benzene rings; C5-7 cycloalkene rings such as cyclopentene rings, cyclohexene rings, and cycloheptene rings; aromatic 5-7 membered heterocyclic rings such as furan rings, thiophene rings, pyrrol rings, imidazole rings, pyrazole rings, thiazole rings, oxazole rings, isoxazole rings, pyridine rings, pyrazine rings, pyrimidine rings, pyridazine rings, azepine rings, and diazepine rings; and unsaturated 5-7 membered heterocyclic rings such as dihydro-2H-pyran rings, dihydro-2H-thiopyran rings, and tetrahydropyridine rings. Of these, aromatic hydrocarbon rings are preferred, and benzene rings are more preferred. In other words, the compounds according to the present invention are preferably compounds having a quinoline ring or a quinoxaline ring.
[0088] [A 1 A 2 A 3 A 4 ] A 1 A 2 A 3 , and A 4 Each of these independently represents a carbon atom or a nitrogen atom. That is, they constitute a benzene ring, pyridine ring, pyridazine ring, pyrimidine ring, pyrazine ring, or triazine ring. However, if B is a carbon atom, then A 1~A 4 It is not the case that all of it consists of carbon atoms. Of these, a pyridine ring is preferred. As for the pyridine ring, A 1 A pyridine ring in which the nitrogen atom is is more preferable.
[0089] The salt of the compound of the present invention is not particularly limited as long as it is an agrohorticulturally acceptable salt. Examples of salts include salts of inorganic acids such as hydrochloric acid and sulfuric acid; salts of organic acids such as acetic acid and lactic acid; salts of alkali metals such as lithium, sodium and potassium; salts of alkaline earth metals such as calcium and magnesium; salts of transition metals such as iron and copper; and salts of organic bases such as ammonia, triethylamine, tributylamine, pyridine and hydrazine.
[0090] The compound represented by formula (I) above is preferably the compound represented by formula (II) (hereinafter sometimes referred to as "compound (II)"). The compound represented by formula (II) is a compound in which "D" in formula (I) is a benzene ring. In other words, the compound of the present invention is preferably a compound having a quinoline ring or a quinoxaline ring.
[0091]
[0092] Here, in equation (II), R, X 1 , m, X 2 , n, A 1 A 2 A 3 A 4 , and B have the same meaning as above.
[0093] The compound represented by formula (II) above is preferably a compound represented by formula (III) (hereinafter sometimes referred to as "compound (III)") or a compound represented by formula (V) (hereinafter sometimes referred to as "compound (V)").
[0094]
[0095] The compound represented by formula (III) is "A" in formula (II). 1 " is a nitrogen atom, "A 2 ~A 4 The compound is one in which the first element is a carbon atom. In other words, the compound of the present invention is preferably a compound having either a quinoline ring or a quinoxaline ring and a pyridine ring. Here, in equation (III), R, X 1 , m, X 2 n and B have the same meaning as above.
[0096] The compound represented by formula (III) above is preferably the compound represented by formula (IV) (hereinafter sometimes referred to as "compound (IV)").
[0097]
[0098] In formula (IV), R, 1 , m, X 2 , and n have the same meaning as above. The compound represented by formula (IV) is a compound in which "B" in formula (III) is a carbon atom. In other words, the compound of the present invention is preferably a compound having a quinoline ring and a pyridine ring.
[0099]
[0100] Compounds represented by formula (V) are those in which "B" in formula (II) is a nitrogen atom, and "A 2 ~A 4 The compound is one in which the ring is a carbon atom. In other words, the compound of the present invention is preferably a compound having a quinoxaline ring and either a benzene ring or a pyridine ring. Here, in equation (V), R, X 1 , m, X 2 , n, and A 1 This has the same meaning as above.
[0101] The compound represented by formula (V) above is preferably the compound represented by formula (VI) (hereinafter sometimes referred to as "compound (VI)").
[0102]
[0103] The compound represented by formula (VI) is "A" in formula (V). 1 The compound is one in which the atom is nitrogen. In other words, the compound of the present invention is preferably a compound having a quinoxaline ring and a pyridine ring. Here, in equation (VI), R, X 1 , m, X 2 , and n have the same meaning as above.
[0104] [Method for producing the compound of the present invention] The compounds of the present invention can be produced, for example, by the synthesis method shown below. (Synthesis method 1)
[0105]
[0106] In the formula, R, 1 , m, X 2 , n, D, and A 1 ~A 4 This has the same meaning as above. Q indicates a halogen atom. A compound represented by formula (1) and a compound represented by formula (2) can be reacted by known methods to produce a compound represented by formula (I-1), which is a type of compound (I) (sometimes referred to as compound (I-1)). In synthesis method 1, 7,8-difluoro-3-iodoquinoline is a useful manufacturing intermediate.
[0107] (Synthesis method 2)
[0108]
[0109] In the formula, Q, R, X 1 , m, X 2 , n, D, and A 1 ~A 4 This has the same meaning as above. Compound (I-1) can be produced by reacting the compound represented by formula (3) with the compound represented by formula (4) by known methods. In synthesis method 2, 8-fluoro-3-hydroxyquinoline, 7,8-difluoro-3-hydroxyquinoline, 8-fluoro-3-hydroxy-2-methylquinoline, or 7,8-difluoro-3-hydroxy-2-methylquinoline are useful manufacturing intermediates.
[0110] (Synthesis method 3)
[0111]
[0112] In the formula, X 1 , m, X 2 , n, D, and A 1 ~A 4 This has the same meaning as above. 1 ', R 2 ' is the aforementioned R 1 ~R 3This refers to an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, or an unsubstituted or substituted alkynyl group. Hal represents a halogen atom.
[0113] Compound (I-3), sometimes referred to as compound (I-2), is produced by reacting one equivalent of Griniard reagent with compound (I-2). Furthermore, reacting compound (I-2) with more than one equivalent of Griniard reagent produces compound (I-4), sometimes referred to as compound (I-4), in addition to compound (I-3), and compound (I-4) can be produced by reacting it with two equivalents of Griniard reagent.
[0114] (Synthesis method 4)
[0115]
[0116] In the formula, R 2 ', Hal, X 1 , m, X 2 , n, D, and A 1 ~A 4 The above has the same meaning. G indicates a leaving group such as an alkoxy group or halogen atom.
[0117] Compound (I-6) can be produced by reacting two equivalents of a compound represented by formula (I-5), which is a type of compound (I), with a compound represented by formula (I-5), which is sometimes called compound (I-5). Furthermore, if compound (I-5) is reacted with an amount greater than two equivalents of a compound represented by formula (I-7), which is sometimes called compound (I-7), is produced in addition to compound (I-6), and compound (I-7) can be produced by reacting it with three equivalents of a compound (I-7).
[0118] (Synthesis method 5)
[0119]
[0120] In the formula, X 1 , m, X 2 , n, D, and A 1 ~A 4 This has the same meaning as above. K 1 and K 2 This indicates an alkyl group.
[0121] The compound represented by formula (I-8) (sometimes referred to as compound (I-8)) can be hydrolyzed by known methods to produce the compound represented by formula (I-9) (sometimes referred to as compound (I-9)). Furthermore, the compound represented by formula (I-10) (sometimes referred to as compound (I-10)) can be synthesized by reacting an alkylating agent in the presence of a base.
[0122] (Synthesis method 6)
[0123]
[0124] In the formula, Hal, R, 1 , m, X 2 , n, D, and A 1 ~A 4 This has the same meaning as above. X 1 ' represents an unsubstituted or substituted alkoxy group, an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, or an unsubstituted or substituted alkynyl group.
[0125] By oxidizing compound (I-1) using a known method such as an oxidizing agent, an N-oxide compound represented by formula (I-11) (sometimes referred to as compound (I-11)) can be produced. By reacting compound (I-11) with a known halogenating agent such as phosphorus oxychloride, a compound represented by formula (I-12) (sometimes referred to as compound (I-12)) can be produced. Then, by subjecting compound (I-12) to a nucleophilic substitution reaction or a coupling reaction using an organometallic catalyst, a compound represented by formula (I-13) (sometimes referred to as compound (I-13)) can be synthesized.
[0126] (Synthesis method 7)
[0127]
[0128] In the formula, R, 1 , m, X 2 , n, D, and A 1 ~A 4 This has the same meaning as above. Q represents a halogen group.
[0129] A compound represented by formula (5) and a compound represented by formula (6) can be reacted by known methods to produce a compound represented by formula (I-14) (sometimes referred to as compound (I-14)).
[0130] (Synthesis method 8)
[0131]
[0132] In the formula, Q, R, X 1 , m, X 2 , n, D, and A 1 ~A 4 This has the same meaning as above.
[0133] Compound (I-14) can be produced by reacting the compound represented by formula (7) with the compound represented by formula (8) by known methods.
[0134] (Synthesis method 9)
[0135]
[0136] In the formula, X 1 , m, X 2 , n, D, and A 1 ~A 4 This has the same meaning as above. 1 ', R 2 ' is the aforementioned R 1 ~R 3 This represents an unsubstituted or substituted alkyl group, an unsubstituted or substituted alkenyl group, or an unsubstituted or substituted alkynyl group. Hal represents a halogeno group.
[0137] A compound represented by formula (I-15), which is a type of compound (I), is mixed with 1 equivalent of Griniard reagent (R 2 By reacting with MgHa (I-15), the compound represented by formula (I-16) (sometimes referred to as compound (I-16)) can be produced. Furthermore, by reacting compound (I-15) with two equivalents or more of a Grinial reagent, the compound represented by formula (I-17) (sometimes referred to as compound (I-17)) can be produced.
[0138] (Synthesis method 10)
[0139]
[0140] In the formula, R 2 ', Hal, X 1 , m, X 2 , n, D, and A 1 ~A 4 The above has the same meaning. G represents a leaving group such as an alkoxy group or a halogeno group.
[0141] Compound represented by formula (I-18), which is a type of compound (I), can be reacted with 2 equivalents of a Griniard reagent to produce a compound represented by formula (I-19), which can be referred to as compound (I-19). Furthermore, compound represented by formula (I-20), which can be referred to as compound (I-20), can be reacted with 3 or more equivalents of a Griniard reagent to produce a compound represented by formula (I-18).
[0142] Salts of compounds (I) to (VI) according to the present invention can be prepared by contacting inorganic acid compounds, organic acid compounds, alkali metal compounds, alkaline earth metal compounds, transition metal compounds, ammonium compounds, etc. with compounds (I) to (VI).
[0143] In all reactions, after the reaction is complete, the target product can be efficiently isolated by performing the usual workup procedures in organic synthesis chemistry and, if necessary, conventionally known separation and purification methods.
[0144] The structure of the object is, 1 Identification and confirmation can be achieved through measurements of H-NMR spectra, IR spectra, and mass spectra, as well as elemental analysis.
[0145] 2) Agricultural and horticultural fungicides The fungicide for agricultural and horticultural use according to the present invention contains at least one selected from the group consisting of nitrogen-containing heterocyclic compounds represented by formulas (I) to (VI) and their salts as an active ingredient.
[0146] The fungicide of the present invention has excellent bactericidal activity against a wide range of filamentous fungi, such as algae (Oomycetes), ascomycetes, deuteromycetes, and basidiomycetes.
[0147] The fungicide of the present invention can be used to control various diseases that occur in the cultivation of agricultural and horticultural crops, including flowers, turf, and pasture grass, by seed treatment, foliar spraying, soil application, or water surface application.
[0148] For example, Sugar beet: Cercospora beticola, Aphanomyces cochlloides, root rot (Thanaphorus cucumeris), leaf rot (Thanatephorus cucumeris); Peanuts: Brown spot disease (Mycosphaerella arachidis), black spot disease (Mycosphaerella berkeleyi); Cucumber: Powdery mildew (Sphaerotheca fuliginea), downy mildew (Pseudoperonospora cubensis), vine blight (Mycosphaerella melonis), vine wilt (Fusarium oxysporum), sclerotinia sclerotiorum, gray mold (Botrytis cinerea), anthracnose (Colletotrichum orbiculare), black spot (Cladosporium cucumerinum), brown spot (Corynespora cassicola), seedling blight (Pythium debaryanam, Rhizoctonia solani Kuhn), bacterial leaf spot (Pseudomonas syringae pv. Lecrymans); Tomatoes: Gray mold (Botrytis cinerea), leaf mold (Cladosporium fulvum), late blight (Phytophthora infestans); Eggplant: Gray mold (Botrytis cinerea), black blight (Corynespora melongenae), powdery mildew (Erysiphe cichoracearum), sooty mold (Mycovellosiella nattrassii); Strawberries: Gray mold (Botrytis cinerea), powdery mildew (Sohaerotheca humuli), anthracnose (Colletotrichum acutatum, Colletotrichum fragariae), late blight (Phytophthora cactorum); Onions: Gray rot (Botrytis allii), gray mold (Botrytis cinerea), white spot leaf blight (Botrytis squamosa), downy mildew (Peronospora destructor); Cabbage: Clubroot (Plasmodiophora brassicae), soft rot (Erwinia carotovora), downy mildew (Peronospora parasitica); Green beans: Sclerotinia sclerotiorum, gray mold (Botrytis cinerea); Apples: Powdery mildew (Podosphaera leucotricha), black spot (Venturia inaequalis), Monilinia mali, black spot (Mycosphaerella pomi), canker (Valsa mali), leaf spot (Alternaria mali), cedar-apple rust (Gymnosporangium yamadae), ring spot (Botryosphaeria berengeriana), anthracnose (Glomerella cingulata, Colletotrichum acutatum), brown spot (Diplocarpon mali), sooty spot (Zygophiala jamaicensis), sooty blotch (Gloeodes pomigena); Persimmon: Powdery mildew (Phyllactinia kakicola), anthracnose (Gloeosporium kaki), horn spot leaf spot (Cercospora kaki);
[0149] Peach: Gray mold (Monilinia fructicola), black spot (Cladosporium carpophilum), Phomopsis rot (Phomopsis sp.); Cherry blossom: Gray mold (Monilinia fructicola); Grapes: Gray mold (Botrytis cinerea), powdery mildew (Uncinula necator), late blight (Glomerella cingulata, Colletotrichum acutatum), downy mildew (Plasmopara viticola), black rot (Elsinoe ampelina), brown spot (Pseudocercospora vitis), black rot (Guignardia bidwellii); Pears: Black spot disease (Venturia nashicola), red-apple rust (Gymnosporangium asiaticum), black spot disease (Alternaria kikuchiana), ring spot disease (Botryosphaeria berengeriana), powdery mildew (Phyllactinia mali); Tea: Ring spot disease (Pestalotia theae), anthracnose (Colletotrichum theae-sinensis); Citrus: Scab (Elsinoe fawcetti), blue mold (Penicillium italicum), green mold (Penicillium digitatum), gray mold (Botrytis cinerea), black spot (Diaporthe citri), canker (Xanthomonas campestris pv. Citri); Wheat: Powdery mildew (Erysiphe graminis f.sp. tritici), Gibberella zeae, Puccinia recondita, brown snow rot (Pythium iwayamai), monographella nivalis, eye spot disease (Pseudocercosporella herpotrichoides), leaf blight (Septoria) tritici), Leptosphaeria nodorum, Typhula incarnata, Myriosclerotinia borealis, Gaeumanomyces graminis;
[0150] Barley: Spotted leaf disease (Pyrenophora graminea), Rhynchosporium secalis, Bare smut (Ustilago tritici, U. nuda); Rice: Pyricularia oryzae, Rhizoctonia solani, Gibberella fujikuroi, Cochliobolus niyabeanus, Pythium graminicolum, Xanthomonas oryzae, Burkholderia plantarii), Acidovorax avenae, Burkholderia glumae; Tobacco: Sclerotinia sclerotiorum, powdery mildew (Erysiphe cichoracearum); Tulips: Gray mold (Botrytis cinerea); Bentgrass: Snow mold (Sclerotinia borealis), Red blight (Pythium aphanidermatum); Orchardgrass: Powdery mildew (Erysiphe graminis); Soybeans: Purple spot disease (Cercospora kikuchii), downy mildew (Peronospora Manshurica), stem blight (Phytophthora sojae); Potatoes and tomatoes: Late blight (Phytophthora infestans); It can be used for controlling pests such as those mentioned above.
[0151] Furthermore, the fungicide of the present invention has excellent fungicidal effects against resistant bacteria. Examples of resistant bacteria include gray mold fungus (Botrytis cinerea), sugar beet brown spot fungus (Cercospora beticola), apple scab fungus (Venturia inaequalis), and pear scab fungus (Venturia nashicola) that are resistant to benzimidazole fungicides such as thiophanate-methyl, benomyl, and carbendazim; and gray mold fungus (Botrytis cinerea) that are resistant to dicarboxyimide fungicides (e.g., vinclozoline, procymidone, iprodione).
[0152] Diseases for which the fungicide of the present invention is more favorably applied include apple scab, cucumber gray mold, wheat powdery mildew, tomato late blight, wheat rust, rice blast, and cucumber wilt.
[0153] Furthermore, the fungicide of the present invention has low phytotoxicity, low toxicity to fish and warm-blooded animals, and is a highly safe agent. The fungicide of the present invention can be used in forms that can be used as pesticides, namely in the form of pesticide formulations such as wettable powders, granules, powders, emulsions, water-soluble powders, suspensions, and granular wettable powders.
[0154] Examples of additives and carriers used in solid formulations include plant-based powders such as soy flour and wheat flour, mineral-based fine powders such as diatomaceous earth, apatite, gypsum, talc, bentonite, pyrophyllite, and clay, and organic and inorganic compounds such as sodium benzoate, urea, and sodium sulfate.
[0155] Examples of solvents used in liquid formulations include kerosene, xylene and petroleum-based aromatic hydrocarbons, cyclohexane, cyclohexanone, dimethylformamide, dimethyl sulfoxide, alcohol, acetone, trichloroethylene, methyl isobutyl ketone, mineral oil, vegetable oil, and water.
[0156] Furthermore, surfactants may be added as needed to ensure that these formulations have a uniform and stable form. The surfactants that can be added are not particularly limited. Examples include nonionic surfactants such as polyoxyethylene-added alkylphenyl ethers, polyoxyethylene-added alkyl ethers, polyoxyethylene-added higher fatty acid esters, polyoxyethylene-added sorbitan higher fatty acid esters, and polyoxyethylene-added tristyrylphenyl ether; sulfate salts of polyoxyethylene-added alkylphenyl ethers, alkylbenzene sulfonates, sulfate salts of higher alcohols, alkylnaphthalene sulfonates, polycarboxylates, lignin sulfonates, formaldehyde condensates of alkylnaphthalene sulfonates, and isobutylene-maleic anhydride copolymers.
[0157] The wettable powder, emulsion, flowable formulation, water-soluble formulation, or granular wettable powder obtained in this manner is used by diluting it with water to a predetermined concentration and spraying it on plants as a solution, suspension, or emulsion. Powders and granules are used by spraying them directly on plants.
[0158] The amount of the active ingredient in the bactericide of the present invention is usually preferably 0.01 to 90% by weight, more preferably 0.05 to 85% by weight, relative to the total formulation.
[0159] The application rate of the fungicide of the present invention varies depending on weather conditions, formulation form, application timing, application method, application location, target disease, target crop, etc., but is usually 1 to 1,000 g of active ingredient per hectare, preferably 10 to 100 g.
[0160] When applying wettable powders, emulsions, suspensions, water-soluble powders, granular wettable powders, etc., diluted with water, the application concentration is 1 to 1,000 ppm, preferably 10 to 250 ppm.
[0161] The fungicide of the present invention can be mixed with other fungicides, insecticides / acaricides, plant growth regulators, and synergists. The following are representative examples of other fungicides, insecticides / acaricides, and plant growth regulators that can be used in combination. Fungicide: (1) Benzimidazole derivatives: benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate-methyl, etc. (2) Dicarboximide derivatives: Clozolinate, iprodione, procymidone, vinclozoline, etc. (3) DMI-fungicides: Imazalil, oxpoconazole, pefurazoate, prochloraz, triflumizole, triforine, pyrifenox, phenalimol, nualimol, azaconazole, vitertanol, bromconazole, cyproconazole, difenoconazole, diniconazole, epoxyconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafor, hexaconazole, imibenconazole, ipconazole, metconazole, mycrobutanil, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, etaconazole, pharconazole, etc. (4) Phenylamide-based: Benalaxyl, Flalaxyl, Metalaxyl, Metalaxyl-M, Oxadixyl, Offrace, etc. (5) Amines: Aldimorph, dodemorph, fenpropimorph, tridemorph, fenpropidine, piperalin, spiroxamine, etc. (6) Phosphothiolates: EDDP, ipropenfos, pyrazofos, etc. (7) Dithiolanes: Isoprothiolanes, etc. (8) Carboxamides: benodanil, boscalid, carboxyne, fenfuran, flutolanil, flametopyr, mepronil, oxycarboxyne, penthiopyrad, tifluzamide, etc. (9) Hydroxy-(2-amino)pyrimidines: Bupyrimate, dimethylimol, ethylimol, etc. (10) AP fungicides (anilinopyrimidine) type: cyprodinil, mepanipyrim, pyrimethanil, etc.
[0162] (11) N-phenylcarbamate systems: diethofencarb, etc. (12) QoI-bactericidal agents (Qo inhibitors): Azoxystrobin, picoxystrobin, pyraclostrobin, kresoxime-methyl, trifloxystrobin, dimoxystrobin, metminostrobin, oryzastrobin, famoxadone, fluoxastrobin, fenamidon, metminofen, etc. (13) PP fungicides (phenylpyrrole) type: fenpiconil, fludioxonil, etc. (14) Quinoline derivatives: quinoxyfen, etc. (15) AH fungicides (aromatic hydrocarbons): biphenyl, chloroneb, dichlorane, quintozen, technazen, tolktophos-methyl, etc. (16) MBI-R series: Fusalide, pyroquilon, tricyclazole, etc. (17) MBI-D system: carpropamide, diclocimet, phenoxanil, etc. (18) SBI agents: fenhexamide, pyributicarb, turbinafin, etc. (19) Phenylurea: Pencyclon, etc. (20) QiI-fungicides (Qi inhibitors): cyazofamide, etc. (21) Benzamide derivatives: Zoxamide, etc. (22) Enopyranurone derivatives: Blastocydin, Mildiomycin, etc. (23) Hexopyranosyl derivatives: Kasugamycin, etc. (24) Glucopyranosyl derivatives: streptomycin, validamycin, etc. (25) Cyanoacetamides: cymoxanil, etc. (26) Carbamate compounds: iodocarb, propamocarb, prothiocarb, polycarbamate, etc. (27) Uncoupling agents: Binapacril, Dinocap, Felimzon, Fluazinam, etc. (28) Organotin compounds: triphenyltin acetate, triphenyltin chloride, triphenyltin hydroxide, etc. (29) Phosphate esters: phosphorous acid, tolclophosmethyl, fosetyl, etc.
[0163] (30) Phthalamitic acid derivatives: Tecrophthalam, etc. (31) Benzotriazine derivatives: triazoxide, etc. (32) Benzene sulfonamide derivatives: fursulfamide, etc. (33) Pyridazinone: diclomedin, etc. (34) CAA fungicides (carboxylic acid amides): Dimethomorph, Flumorph, Benciavaricarb, Iprovaricarb, Mandipropamide, etc. (35) Tetracyclines: Oxytetracycline, etc. (36) Thiocarbamate derivatives: metasulfocarb, etc. (37) Other compounds: etridiazole, polyoxin, oxolinic acid, hydroxyisoxazole, octinoline, silthiofam, diflumetrim, acibenzolar-S-methyl, probenazole, thiadinyl, etaboxam, cyflufenamid, proquinazide, metraphenone, fluopicolide, cupric hydroxide, organocopper, sulfur, falbam, manzeb, maneb, methylam, propineb, thiram, zineb, ziram, captan, captafol, forpet, chlorothalonil, diclofluanide, tolfluanide, dozin, guazatin, iminoctadine acetate, iminoctadine dodecylbenzenesulfonate, anilazine, dithianone, chloropicrin, dazomet, quinomethionate, cyproflam, silthiofam, agrobacterium, fluorimide), etc.
[0164] Insecticides, acaricides, nematicides, soil pesticides, anthelmintics: (1) Organic (thio) phosphates: Acephate, Azamethiphos, Adinphos-methyl, Adinphos-ethyl, Bromophos-ethyl, Bromfenbinphos, BRP, Chlorpyrifos, Chlorpyrifos-methyl, Chlorpyrifos-ethyl, Chlorfenbinphos, Kazusaphos, Carbophenothion, Chlorethoxyphos, Chlormephos, Coumaphos, Cyanophenphos, Cyanophos, CYAP, Diazinon, Dichlorvos, Diclotophos, Dimethoate, Disulfon, Dimeton-S-methyl, Dimethylbinphos, Dimeton-S-methylsulfone, Dialiphos, Diazinon, Diclofenthion, Dioxabenzophos, Disulfon, Ethion, Etoprophos, Etrimophos, EPN, Phenamiphos, Fenitrothion, Fenthion, Fensulfothion, Flupyrazophos, Honophos, Formothion On, fosmethilane, heptenofos, isazofos, iodophenphos, isofenphos, isoxathion, iprobenphos, malathion, mevinphos, methamidophos, methidathion, monoclotophos, mecarbam, methacryphos, naled, omethoate, oxydimeton methyl, paraoxone, parathion, parathion methyl, fenthoate, fosalon, fosmet, phosphamidon, pholate, phoxim, pirimiphos methyl, pirimiphos ethyl, profenophos, prothiophos, fostiazate, phosphocarb, propaphos, propetamphos, protoate, pyridaphenthion, pyraclophos, quinalphos, salition, sulprophos, sulfotep, tetrachlorvinphos, terbuphos, triazophos, trichlorfon, tebupyrimphos, temephos, thiometon, bamidothion; (2) Carbamates: Alanicarb, Aldicarb, Bendiocarb, Benfuracarb, Carbaryl, Carbofuran, Carbosulfan, Phenoxycarb, Phenothiocarb, Methiocarb, Methomyl, Oxamyl, Pyrimicacarb, Propoxul, Thiodicarb, Triazamate, Ethiofencarb, Phenobucarb, MIPC, MPMC, MTMC, Pyridafenthion, Furobucarb, XMC, Aldoxycarb, Alixicarb, Aminocarb, Bendiocarb, Bufencarb, Butacarb, Butocarboxime, Butoxycarboxime, Chloetocarb, Dimethilane, Formetanate, Isoprocarb, Metam sodium, Metolcarb, Promecarb, Thiofanox, Trimetacarb, Xylylcarb; (3) Pyretroids: Allethrin, bifenthrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cyphenothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, zeta-cypermethrin, deltamethrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, imiprothrin, permethrin, prallethrin, pyrethrin, pyrethrin I, pyrethrin II, resmethrin, silafluofen, fluvalinate Tefluthrin, tetramethrin, tralomethrin, transfluthrin, profluthrin, dimefluthrin, acrinatrin, cycloprothrin, halfenprox, flucitrinate, bioalethrin, bioetanomethrin, biopermethrin, bioresmethrin, transpermethrin, empenthrin, fenfluthrin, fenpyritrin, flubrocitrinate, flufenprox, flumethrin, metofluthrin, phenothrin, protrefenbut, pyrethmethrin, teralethrin; (4) Growth regulators: (a) Chitin synthesis inhibitors: Chlorfluazurone, diflubenzuron, flucycloxurone, flufenoxurone, hexaflumurone, lufenuron, novaron, teflubenzuron, triflumuron, bistriflumurone, nobiflumuron, buprofezin, hexythiazox, etoxazole, clofentezine, fluazurone, penfluron; (b) Ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide, chromafenozide, azadirachtin; (c) Juvenile hormone-like substances: pyriproxyfen, methoprene, diofenolan, epophenonane, hydroprene, quinoprene, triprene; (d) Lipid biosynthesis inhibitors: spirodiclofen, spiromesifen, spirotetramat, flonicamide; (5) Nicotinic receptor agonist / antagonist compounds: acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid, thiamethoxam, nithiazine, nicotine, bensultap, cartap, flupyradiflon; (6) GABA antagonist compounds: (a) Acetoprole, ethiprole, fipronil, vaniliprole, pyrafuruprole, pyriprole; (b) Organochlorine compounds; campechlor, chlordane, endosulfan, HCH, γ-HCH, heptachlor, methoxychlor (7) Macrocyclic lactone insecticides: abamectin, emamectin benzoate, milbemectin, lepimectin, spinosad, ivermectin, selamectin, doramectin, epinomectin, moxidectin, (8) METI I compounds: phenazaquine, pyridaben, tebufenpyrad, tolfenpyrad, fluphenerim, hydramethylnon, fenpyroximate, pyrimidifen, dicofol; (9) METI II and III compounds: acequinosyl, fluacrypyrim, rotenone; (10) Uncoupling agent compounds: chlorfenapyr, binapacril, dinovton, dinocap, DNOC;
[0165] (11) Oxidative phosphorylation inhibitor compounds: cyhexatine, diafenthiurone, fenbutine oxide, propargit, azocyclotin; (12) Molting disruption compound: cyromazine; (13) Mixed-function oxidase inhibitor compound: piperonyl butoxide; (14) Sodium channel blocker compounds: indoxacarb, metaflumizone; (15) Microbial pesticides: BT agents, entomopathogenic virus agents, entomopathogenic fungal agents, nematopathogenic fungal agents; Bacillus species, white mussel fungus, black mussel fungus, Pechylomyces species, Thuringiensin, Verticillium species; (16) Latrophyllin receptor agonists: depsipeptides, cyclic depsipeptides, 24-membered cyclic depsipeptides, emodepsides; (18) Octopamine agonists: Amitraz; (19) Rianodine derivative agonists: flubendiamide, chlorantraniliprole, cyantraliniprole
[0166] (20) Magnesium-stimulated ATPase inhibitors: thiocyclam, thiosultap, nereistoxin; (21) Feeding inhibitors: Pymetrozine; (22) Mite growth inhibitors: Clofentezine, etoxazole; (23) Others: Bencrotiaz, bifenazate, pyridaryl, sulfur, cyenopyrafen, cyflumetofen, amidoflumet, tetradiphon, chlordimeform, 1,3-dichloropropene, DCIP, phenisobromolate, benzomate, metaldehyde, spinetoram, pyrifluquinazone, benzoximate, bromopropylate, quinomethionate, chlorbenzilate, chloropicrin, clothiazoben, dicyclanil, phenoxacrim, fentriphanil, flubendimine, flufenzin, gossipplea, japonila, methoxadiazone, petroleum, potassium oleate, sulfuramide, tetrasul, trialacene; (24) Insecticides (a) Benzimidazole derivatives: fenbendazole, albendazole, triclabendazole, oxybendazole; (b) Salicylanilide derivatives: Closantel, oxyclozanide; (c) Substituted phenolic system: Nitroxynyl; (d) Pyrimidines: pyrantel; (e) Imidazothiazole derivatives: Lebamisol; (f) Tetrahydropyrimidine: praziquantel; (g) Other anthelmintics: cyclodiene, liania, chlorthrone, metronidazole;
[0167] Plant growth regulators: Abscisic acid, indole butyrate, uniconazole, eticlozate, etephon, cloxifonac, chlormecoat, chlorella extract, calcium peroxide, cyanamide, dichlorprop, gibberellin, daminozide, decyl alcohol, trinexapac ethyl, mepicort chloride, paclobutrazol, paraffin wax, piperonyl butoxide, pyraflufen ethyl, flurprimidol, prohydrojasmon, prohexadione calcium salt, benzylaminopurine, pendimethalin, forchlorfenuron, potassium hydrazide maleate, 1-naphthylacetamide, 4-CPA, MCPB, choline, oxyquinoline sulfate, eticlozate, butruarin, 1-methylcyclopropene, abiglycine hydrochloride.
[0168] Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited in any way by the following examples.
[0169] Example 1 Synthesis of 3-(2-cyanopyridine-3-yloxy)-8-fluoro-2-methylquinoline
[0170]
[0171] 4.9 g of 8-fluoro-3-hydroxy-2-methylquinoline, 3.2 g of 3-chloro-2-cyanopyridine, and 3.8 g of potassium carbonate were dissolved in 20 ml of N-methylpyrrolidone and stirred at 130°C for 3 hours. The reaction mixture was then cooled to room temperature, water was added, and the mixture was extracted with ethyl acetate. The extract was washed with saturated saline solution, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The resulting residue was purified by silica gel column chromatography. 5.37 g of 3-(2-cyanopyridine-3-yloxy)-8-fluoro-2-methylquinoline was obtained.
[0172] Example 2 Synthesis of 1-[3-(2-methyl-8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-ethanone (compound number a-9)
[0173]
[0174] 2.51 g of 3-(2-cyanopyridine-3-yloxy)-8-fluoro-2-methylquinoline was dissolved in 30 ml of dehydrated tetrahydrofuran. 3.6 ml of 3 M tetrahydrofuran solution of methylmagnesium chloride was added dropwise under ice cooling, and the reaction mixture was stirred under ice cooling for 2 hours. Then, this was added to a 1 N hydrochloric acid solution, neutralized with sodium bicarbonate solution, and then extracted with ethyl acetate. The extract was washed with saturated saline solution, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The resulting residue was purified by silica gel column chromatography. 1.7 g of 1-[3-(2-methyl-8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-ethanone was obtained.
[0175] Example 3 Synthesis of 2-[(8-fluoro-2-methylquinoline-3-yloxy)pyridine-2-yl]propan-2-ol (compound number a-7)
[0176]
[0177] 1.58 g of 1-[3-(2-methyl-8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-ethanone was dissolved in 20 ml of dehydrated tetrahydrofuran. 2.7 ml of 3 M tetrahydrofuran solution of methylmagnesium chloride was added dropwise under ice cooling, and the reaction mixture was stirred under ice cooling for 3 hours. This was then added to a 1 N hydrochloric acid solution, neutralized with sodium bicarbonate solution, and extracted with ethyl acetate. The extract was washed with saturated saline solution, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The resulting residue was purified by silica gel column chromatography. 1.69 g of 2-[(8-fluoro-2-methylquinoline-3-yloxy)pyridine-2-yl]propan-2-ol was obtained.
[0178] Example 4 Synthesis of 3-[2-(2-methoxy-2-propyl)pyridine-3-yloxy]-8-fluoro-2-methylquinoline (compound number a-16)
[0179]
[0180] 0.50 g of 2-[(8-fluoro-2-methylquinoline-3-yloxy)pyridine-2-yl]propan-2-ol and 0.45 g of methyl iodide were dissolved in 10 ml of dimethylformamide. 64 mg of sodium hydride (60% oil dispersion) was added to this mixture under ice cooling, and the reaction mixture was stirred under ice cooling for 2 hours. Then, this was poured into ice water and extracted with ethyl acetate. The extract was washed with saturated saline solution, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The resulting residue was purified by silica gel column chromatography. 0.15 g of 3-[2-(2-methoxy-2-propyl)pyridine-3-yloxy]-8-fluoro-2-methylquinoline was obtained.
[0181] Example 5 Synthesis of 3-[2-(2-ethoxy-2-propyl)pyridine-3-yloxy]-8-fluoro-2-methylquinoline (compound number a-56)
[0182]
[0183] 0.53 g of 2-[(8-fluoro-2-methylquinoline-3-yloxy)pyridine-2-yl]propan-2-ol was dissolved in 10 ml of chloroform. 0.61 g of thionyl chloride was added at room temperature and the mixture was stirred for 30 minutes at room temperature. The solvent and excess thionyl chloride were then removed under reduced pressure, and the resulting residue was dissolved in ethanol. 0.67 g of pyridine was added, and the mixture was heated under reflux for 1 hour. The mixture was then concentrated under reduced pressure, the residue was added to water, and extracted with ethyl acetate. The extract was washed with saturated saline solution, dried over magnesium sulfate, and the solvent was removed under reduced pressure. The resulting residue was purified by silica gel column chromatography. 0.19 g of 3-[2-(2-ethoxy-2-propyl)pyridine-3-yloxy]-8-fluoro-2-methylquinoline was obtained.
[0184] Example 6 Synthesis of 2-[3-(8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-2-methylpropionitrile (compound number a-11) Step 1) Synthesis of 2-(3-bromopyridine-2-yl)-2-methylpropionitrile
[0185] 2.25 g of (3-bromopyridine-2-yl)acetonitrile was dissolved in 30 ml of dimethylformamide. 1.09 g of sodium hydride (60% oil dispersion) was added at 0°C. Subsequently, 3.9 g of methyl iodide was added to the reaction mixture and stirred for 1.5 hours. Then, dilute hydrochloric acid was added and the mixture was extracted with ethyl acetate. The solvent in the organic layer was removed by distillation and the mixture was purified by silica gel column chromatography. 2.68 g of 2-(3-bromopyridine-2-yl)-2-methylpropionitrile was obtained.
[0186] Step 2) Synthesis of 2-[3-(8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-2-methylpropionitrile
[0187]
[0188] 1.35 g of 2-(3-bromopyridine-2-yl)-2-methylpropionitrile was dissolved in 6 ml of N-methylpyrrolidone. To this, 0.82 g of 8-fluoro-3-hydroxyquinoline, 1.95 g of cesium carbonate, 0.18 g of dipivaloylmethane, and 0.50 g of copper(I) chloride were added and the mixture was stirred at 130°C for 23 hours. The reaction mixture was then cooled to room temperature and purified by silica gel column chromatography. 0.46 g of 2-[3-(8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-2-methylpropionitrile was obtained.
[0189] Example 7 Synthesis of 2-[3-(8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-2-methylpropionate ethyl ester (compound number a-12)
[0190]
[0191] 0.38 g of 2-[3-(8-fluoro-quinoline-3-yloxy)-pyridine-2-yl]-2-methylpropionitrile was mixed with 2 ml of ethanol and 2 ml of concentrated sulfuric acid. The mixture was stirred at 100°C for 6 hours. Then, saturated sodium bicarbonate aqueous solution was added to stop the reaction. The mixture was extracted with ethyl acetate, and the solvent in the organic layer was removed by distillation. The mixture was then purified by silica gel column chromatography. 0.24 g of ethyl 2-[3-(8-fluoro-quinoline-3-yloxy)-pyridine-2-yl]-2-methylpropionate was obtained.
[0192] Example 8 Synthesis of 2-[3-(8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-2-methylpropionic acid (compound number a-19)
[0193]
[0194] 0.33 g of ethyl ester 2-[3-(8-fluoro-quinoline-3-yloxy)-pyridine-2-yl]-2-methylpropionate was dissolved in 1 ml of ethanol. 2 ml of 4N aqueous sodium hydroxide solution was added to this solution. The mixture was heated under reflux for 48 hours. Then, dilute hydrochloric acid was added and the mixture was extracted with ethyl acetate, and the solvent of the organic layer was removed by distillation. 0.25 g of 2-[3-(8-fluoro-quinoline-3-yloxy)-pyridine-2-yl]-2-methylpropionic acid was obtained.
[0195] Example 9 Synthesis of N-ethyl-2-[3-(8-fluoroquinoline-3-yloxy)-pyridine-2-yl]isobutylamide (compound number a-55)
[0196]
[0197] 0.10 g of 2-[3-(8-fluoro-quinoline-3-yloxy)-pyridine-2-yl]-2-methylpropionic acid and 0.08 g of diisopropylethylamine were dissolved in 1.2 ml of dimethylformamide. To this, 0.3 ml of 2.0 M tetrahydrofuran solution of ethylamine and 0.17 g of O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate were added and the mixture was stirred at room temperature for 14 hours. The mixture was then extracted with ethyl acetate, and the solvent of the organic layer was removed by distillation. The mixture was purified by silica gel column chromatography. 0.10 g of N-ethyl-2-[3-(8-fluoro-quinoline-3-yloxy)-pyridine-2-yl]-isobutylamide was obtained.
[0198] Example 10 Synthesis of 2-[3-(8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-2-methylpropioaldehyde (compound number a-21) Step 1) Synthesis of 2-(3-bromopyridine-2-yl)-2-methylpropioaldehyde
[0199] 1.8 g of 2-(3-bromopyridine-2-yl)-2-methylpropionitrile was dissolved in 20 ml of toluene. 5.9 ml of a 25 wt% toluene solution of diisobutylaluminum hydride was added at 0°C. The mixture was stirred at room temperature for 17 hours. Then, dilute hydrochloric acid was added to decompose the unreacted diisobutylaluminum hydride. Saturated sodium bicarbonate aqueous solution was then added, followed by extraction with ethyl acetate. The solvent of the organic layer was removed by distillation. The mixture was purified by silica gel column chromatography. 0.44 g of 2-(3-bromopyridine-2-yl)-2-methylpropioaldehyde was obtained.
[0200] Step 2) Synthesis of 2-[3-(8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-2-methylpropioaldehyde
[0201]
[0202] 0.41 g of 2-(3-bromopyridine-2-yl)-2-methylpropioaldehyde was dissolved in 4 ml of N-methylpyrrolidone. To this, 0.59 g of 8-fluoro-3-hydroxyquinoline, 1.2 g of cesium carbonate, 0.07 g of dipivaloylmethane, and 0.18 g of copper(I) chloride were added and the mixture was stirred at 130°C for 16 hours. The reaction mixture was then cooled to room temperature and purified by silica gel column chromatography. 0.19 g of 2-[3-(8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-2-methylpropioaldehyde was obtained.
[0203] Example 11 Synthesis of 3-[3-(8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-3-methylbutan-2-ol
[0204]
[0205] 0.10 g of 2-[3-(8-fluoro-quinoline-3-yloxy)-pyridine-2-yl]-2-methyl-propioaldehyde was dissolved in 3 ml of tetrahydrofuran. To this, 0.2 ml of 3.0 M tetrahydrofuran solution of methylmagnesium chloride was added at 0°C and the mixture was stirred at 0°C for 30 minutes. Then, water was added to stop the reaction. This was extracted with ethyl acetate and the solvent of the organic layer was removed by distillation. The mixture was purified by silica gel column chromatography. 0.07 g of 3-[3-(8-fluoro-quinoline-3-yloxy)-pyridine-2-yl]-3-methyl-butan-2-ol was obtained.
[0206] Example 12 Synthesis of 3-[3-(8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-3-methylbutan-2-one (compound number a-15)
[0207]
[0208] 0.07 g of 3-[3-(8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-3-methylbutan-2-ol was dissolved in 3 ml of dichloromethane. 0.27 g of Dess-Martin reagent was added at 0°C and the mixture was stirred for 30 minutes. The reaction mixture was then concentrated and purified by silica gel column chromatography. 0.04 g of 3-[3-(8-fluoroquinoline-3-yloxy)-pyridine-2-yl]-3-methylbutan-2-one was obtained.
[0209] Next, the manufacturing intermediates of the compounds of the present invention will be described in more detail with reference to the following examples, but the manufacturing intermediates are not limited in any way by the following reference examples.
[0210] Reference example 1 Synthesis of 7,8-difluoro-3-hydroxy-2-methylquinoline
[0211] Step 1) Synthesis of 6,7-difluoroisatin
[0212]
[0213] 15.7 g of 2,3-difluoroaniline was added to 825 mL of water, followed by 24.2 g of trichloroacetaldehyde monohydrate, 30.8 g of hydroxyamine hydrochloride, and 138.6 g of anhydrous sodium sulfate, and the mixture was stirred at 50°C for 10 hours. The mixture was cooled to room temperature. Then, 44 mL of 2N hydrochloric acid was added and the mixture was stirred for 30 minutes. The crystals were then removed by filtration. The obtained crystals were dried and added to hot concentrated sulfuric acid at 70°C, and the mixture was stirred at 80-90°C for 1 hour. The reaction mixture was poured onto ice and extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over magnesium sulfate, and the solvent was removed under reduced pressure. 26 g of crude 6,7-difluoroisatin was obtained.
[0214] Step 2) Synthesis of 7,8-difluoro-3-hydroxy-2-methylquinoline
[0215]
[0216] 41 g of the crude product of 6,7-difluoroisatin was added to 200 mL of water, and 75.3 g (6 equivalents) of potassium hydroxide was added under ice cooling, and the mixture was stirred for 30 minutes. 42 g (1.4 equivalents) of bromoacetophenone was added dropwise to this suspension at a temperature of 20–25°C. After the addition was complete, the mixture was stirred at room temperature overnight. This was neutralized with concentrated hydrochloric acid. The precipitated crystals were removed by filtration and washed with a small amount of water. The obtained crystals were dried and added little by little to 100 mL of nitrobenzene at 130–140°C. After the addition was complete, the mixture was stirred at 150°C for 1 hour. The reaction mixture was cooled to room temperature. The precipitated crystals were washed with chloroform. 26.3 g of 7,8-difluoro-3-hydroxy-2-methylquinoline was obtained. The NMR analysis results of the product were as follows. 1 H NMR (300 MHz, DMSO-d6) δ2.57 (s, 3H), 7.4-7.7 (m, 3H), 10.60 (bs, 1H).
[0217] 8-fluoro-3-hydroxy-2-methylquinoline was produced by a similar method. The NMR analysis results of the product were as follows. 1 H NMR (300 MHz, DMSO-d6) δ2.56 (s, 3H), 7.2-7.6 (m, 4H), 10.53 (bs, 1H).
[0218] Reference example 2 Synthesis of 7,8-difluoro-3-hydroxyquinoline
[0219] Step 1) Synthesis of 7,8-difluoroquinoline
[0220]
[0221] 607.7 g (49.57 mol) of 80% sulfuric acid was placed in a 3 L round-bottom flask containing a stirring bar and cooled to 0°C. 160.0 g (1.24 mol) of 2,3-difluoroaniline was gradually added. After the addition was complete, the mixture was stirred at room temperature for 1 hour. 1.85 g (12.3 mmol) of sodium iodide was added and the mixture was heated in an oil bath at 150°C. When the liquid temperature reached 150°C, 125.5 g (1.36 mol) of glycerin was added dropwise over 1 hour. After the addition was complete, the mixture was stirred at 150°C for 1 hour. The oil bath temperature was then raised to 180°C. Water was removed by distillation over 2 hours using a distillation apparatus. After confirming the disappearance of the raw materials, the mixture was neutralized with a 10 N sodium hydroxide aqueous solution while cooling in an ice bath (internal temperature 60-70°C). After neutralization, the solution was extracted with ethyl acetate before the internal temperature returned to room temperature, dried over magnesium sulfate, filtered, and concentrated. The resulting crude product was purified by silica gel column chromatography (n-hexane:ethyl acetate). 185.5 g (91%) of 7,8-difluoroquinoline was obtained as a light brown solid.
[0222] Step 2) Synthesis of 7,8-difluoro-3-iodoquinoline
[0223]
[0224] In a 3 L round-bottom flask containing a stirring bar, 185.5 g (1.12 mol) of 7,8-difluoroquinoline, 505.4 g (2.25 mol) of N-iodosuccinimide, and 927 mL of acetic acid were added and stirred at 90°C for 30 hours. The mixture was then cooled. The precipitated crystals were filtered and dried. The filtrate was concentrated under reduced pressure, the remaining acetic acid was neutralized with sodium bicarbonate, and then extracted with ethyl acetate. The extract was dried over magnesium sulfate, filtered, and concentrated. The resulting crude product was purified by silica gel column chromatography (n-hexane:ethyl acetate). Together with the previously obtained crystals, 227.2 g (70%) of 7,8-difluoro-3-iodoquinoline was obtained as a light brown solid. The NMR analysis results of the product were as follows. 1 H-NMR (300MHz, CDCl3) δ7.39-7.51 (m, 2 H), 8.55 (m, 1H), 9.08 (d, 1H, J = 2.1Hz).
[0225] Step 3) Synthesis of 7,8-difluoro-3-hydroxyquinoline
[0226]
[0227] 227.2 g (0.78 mol) of 7,8-difluoro-3-iodoquinoline, 600 mL of dimethyl sulfoxide, and 600 mL of water were placed in a 3 L round-bottom flask containing a stirring bar. To this, 131.5 g (2.34 mol) of potassium hydroxide, 14.8 g (0.078 mol) of CuI, and 28.1 g (0.156 mol) of 1,10-phenanthroline were added. The mixture was heated to 100°C in an oil bath and stirred for 24 hours. After that, it was cooled. Ethyl acetate and water were added, and the organic layer was removed. The resulting aqueous layer was neutralized with concentrated hydrochloric acid. The precipitated crystals were filtered and dried. The filtrate was extracted with ethyl acetate, dried over magnesium sulfate, filtered, and concentrated. The resulting crude product was purified by silica gel column chromatography (n-hexane:ethyl acetate). Together with the previously obtained crystals, 133.7 g (95%) of 7,8-difluoro-3-hydroxyquinoline was obtained as a light brown solid. The NMR analysis results of the product were as follows. 1 H-NMR (300MHz, CD3OD) δ7.39-7.60 (m, 3H), 8.59 (d, 1H, J = 2.4Hz).
[0228] 8-fluoro-3-hydroxyquinoline was produced by a similar method. The NMR analysis results of the product were as follows. 1 H-NMR (300MHz, CDCl3) δ7.16 (m, 1H), 7.34-7.49 (m, 3H), 8.71 (d, 1H, J = 2.7Hz), 9.90 (bs, 1H).
[0229] Reference example 3 Synthesis of 7-fluoro-3-hydroxy-2-methylquinoline
[0230] Step 1) Synthesis of 6-fluoroisatin
[0231]
[0232] 9.6 g of 3-fluoroaniline was added to 590 mL of water, followed by 17.2 g of trichloroacetaldehyde monohydrate, 21.9 g of hydroxyamine hydrochloride, and 98.2 g of anhydrous sodium sulfate. The mixture was stirred at 50°C for 5 hours. After cooling to room temperature and standing overnight, 31 mL of 2N HCl was added and the mixture was stirred for 30 minutes. The crystals were then collected by filtration. After drying the obtained crystals, they were added to concentrated sulfuric acid heated to 70°C and stirred at 80-90°C for 1 hour. The reaction mixture was poured onto ice, extracted with ethyl acetate, and washed with saturated brine. The organic layer was dried over magnesium sulfate, and the solvent was removed under reduced pressure to obtain 7.96 g of crude 6-fluoroisatin.
[0233] Step 2) Synthesis of 7-fluoro-3-hydroxy-2-methylquinoline
[0234]
[0235] 7.96 g of crude 6-fluoroisatin was added to 55 mL of water, and 16.2 g (6 equivalents) of KOH was added under ice cooling and stirred for 30 minutes. 9.9 g (1.5 equivalents) of bromoacetophenone was added dropwise to this suspension while maintaining the internal temperature of the reaction mixture at 20–25°C, and the mixture was stirred overnight at room temperature. After neutralization with concentrated hydrochloric acid, the precipitated crystals were collected by filtration and washed with a small amount of water. After thoroughly drying the obtained crystals, they were added little by little to 70 mL of nitrobenzene heated to 120–130°C, and the mixture was stirred at 140–150°C for 1 hour. After the reaction mixture was cooled to room temperature, the precipitated crystals were washed with chloroform to obtain 5.4 g of 7-fluoro-3-hydroxy-2-methylquinoline. The NMR analysis results of the product were as follows: 1 H NMR (300 MHz, DMSO-d6) δ 2.56 (s, 3H), 7.32-7.38 (m, 1H), 7.53-7.57 (m, 1H), 7.80-7.84 (m, 1H).
[0236] Example 13 Synthesis of 3-[2-fluoro-6-(5-fluoro-quinoxaline-2-yloxy)phenyl]-3-methylbutan-2-one
[0237]
[0238] The 2-chloro-5-fluoroquinoxaline used as a raw material was synthesized according to the method described in Non-Patent Document 1. 0.32 g of 3-(2-fluoro-6-hydroxy-phenyl)-3-methyl-butan-2-one and 0.28 g of 2-chloro-5-fluoro-quinoxaline were dissolved in 3 ml of dimethylformamide. 0.25 g of potassium carbonate was added to this mixture and the mixture was stirred at 100°C for 2 hours. The reaction mixture was then purified by silica gel column chromatography to obtain 0.14 g of 3-[2-fluoro-6-(5-fluoro-quinoxaline-2-yloxy)-phenyl]-3-methyl-butan-2-one.
[0239] Example 14 Synthesis of 2-chloro-6-(5,6,7,8-tetrahydroquinoxaline-2-yloxy)-benzaldehyde
[0240]
[0241] The tetrahydroquinoxalone used as a raw material was synthesized according to the method described in Patent Document 5. 0.3 g of 5,6,7,8-tetrahydroquinoxaline-2-ol was dissolved in 5 ml of dimethylformamide. 0.1 g of sodium hydride was added to this solution. 0.35 g of 2-chloro-6-fluoro-benzaldehyde was added to the reaction solution and the mixture was stirred at 100°C for 3 hours. 1 N hydrochloric acid was added to the reaction solution. The mixture was then extracted with ethyl acetate. The organic layer was concentrated and purified by silica gel column chromatography to obtain 0.26 g of 2-chloro-6-(5,6,7,8-tetrahydroquinoxaline-2-yloxy)-benzaldehyde.
[0242] Example 15 Synthesis of 5,6-difluoro-2-[2-(1-methoxy-1-methyl-ethyl)-pyridine-3-yloxy]-3-methylquinoxaline
[0243]
[0244] 0.17 g of 2-chloro-5,6-difluoro-3-methylquinoxaline was dissolved in 2 mL of N-methylpyrrolidone. 0.13 g of 2-(1-methoxy-1-methyl-ethyl)-pyridine-3-ol and 0.11 g of potassium carbonate were added, and the mixture was stirred at 100°C for 3 hours. The reaction solution was then purified by silica gel column chromatography to obtain 0.24 g of 5,6-difluoro-2-[2-(1-methoxy-1-methyl-ethyl)-pyridine-3-yloxy]-3-methylquinoxaline.
[0245] The nitrogen-containing heterocyclic compounds obtained in the above examples, and nitrogen-containing heterocyclic compounds synthesized by the same method as in any of the above examples, are shown in Tables 1 and 2. R in Table 1 1 , R 2 , R 3 , (X 1 ) m , and (X 2 ) n These represent those in equation (1-A). R in Table 2 1 , R 2 , R 3 , (X 1 ) m A 1 ~A 4 , and (X 2 ) n These represent those in equation (1-B). Also, the n listed in the physical properties section. D The symbol indicates the refractive index (the superscript number indicates the measurement temperature (°C)).
[0246]
[0247]
[0248]
[0249]
[0250]
[0251]
[0252]
[0253]
[0254]
[0255]
[0256] Of the compounds listed in the table above, those marked with an asterisk (*) in the physical properties column: 1 H-NMR (300 MHz, CDCl3)δ was measured. Some of the measurement results are shown below. Compound a-2: 1.67 (s, 6H), 6.00 (s, 1H), 7.54-7.61 (m, 2H), 7.66-7.74 (m, 2H), 8.14 (d, 1H), 8.38 (t, 1H), 8.80 (d, 1H). Compound a-7: 1.66 (s, 6H), 2.81 (s, 3H), 6.02 (s, 1H), 7.19-7.43 (m, 6H), 8.40 (d, 1H). Compound a-8: 1.65 (s, 6H), 5.96 (s, 1H), 7.25-7.39 (m, 3H), 7.48-7.58 (m, 3H), 8.41 (m, 1H), 8.85 (d, 1H). Compound a-12: 1.07 (t, 3H), 1.66 (s, 6H), 3.88 (q, 2H), 7.23-7.27 (m, 2H), 7.34 (m, 1H), 7.46-7.50 (m, 2H), 7.58 (m, 1H), 8.45 (d, 1H), 8.76 (d, 1H). Compound a-20: 1.65 (s, 6H), 2.98 (s, 3H), 3.23 (s, 3H), 7.17-7.22 (m, 2H), 7.34 (m, 1H), 7.46-7.52 (m, 2H), 7.64 (m, 1H), 8.44 (dd, 1H), 8.75 (d, 1H). Compound a-22: 1.05 (t, 3H), 1.66 (s, 6H), 2.79 (s,3H), 3.80 )q, 2H), 7.25-7.35 (m, 3H), 7.40-7.50 (m, 3H), 8.45 (m, 1H). Compound a-33: 1.88 (s, 6H), 7.10-7.29 (m, 2H), 7.40-7.50 (m, 2H), 7.70 (m, 1H), 8.42 (d, 1H), 8.91 (d, 1H).
[0257] Compound a-43: 1.08 (t, 3H), 1.46-1.65 (m, 2H), 3.88 (d, 1H), 4.63 (br, 1H), 7.20-7.34 (m, 3H), 7.48-7.50 (m, 3H), 8.39 (m, 1H), 8.83 (d, 1H). Compound a-44: 1.58 (s, 6H), 3.17 (s, 3H), 3.69 (s, 2H), 7.18–7.26 (m, 2H), 7.34 (m, 1H), 7.44–7.49 (m, 3H), 8.48 (m, 1H), 8.86 (d, 1H). Compound a-45: 0.96 (t, 3H), 1.59 (s, 6H), 2.50 (q, 2H), 7.19–7.23 (m, 2H), 7.34 (m, 1H), 7.48–7.51 (m, 2H), 7.57 (m, 1H), 8.47 (m, 1H), 8.74 (d, 1H). Compound a-46: 1.07 (t, 3H), 1.84 (s, 3H), 2.05 (m, 1H), 2.38 (m, 1H), 7.24-7.40 (m, 3H), 7.49-7.51 (m, 2H), 7.66 (m, 1H), 8.43 (d, 1H), 8.85 (d, 1H). Compound a-48: 0.85 (t, 3H), 1.07 (t, 3H), 1.61 (s, 6H), 2.04-2.26 (m, 2H), 3.86 (q, 2H), 7.24-7.26 (m, 2H), 7.34 (m, 1H), 7.48-7.50 (m, 2H), 7.58 (m, 1H), 8.46 (m, 1H), 8.76 (d, 1H).
[0258] Compound a-74: 1.09 (d, 6H), 1.64 (s, 3H), 4.83 (m, 1H), 7.19-7.26 (m, 2H), 7.43-7.46 (m, 2H), 7.59 (s, 1H), 8.44 (m, 1H), 8.81 (d, 1H). Compound a-75: 1.67 (s, 6H), 3.43 (s, 3H), 7.22-7.38 (m, 3H), 7.48-7.50 (m, 2H), 7.60 (m, 1H), 8.45 (m, 1H), 8.75 (d, 1H). Compound a-76: 1.05 (d, 6H), 1.66 (s, 6H), 2.80 (s, 3H), 4.78 (m, 1H), 7.20-7.33 (m, 3H), 7.38-7.40 (m, 3H), 8.44 (m, 1H). Compound a-77: 1.05 (d, 6H), 1.65 (s, 6H), 2.80 (s, 3H), 4.77 (m, 1H), 7.17-7.26 (m, 2H), 7.32-7.38 (m, 3H), 8.44 (m, 1H). Compound a-78: -0.07 (s, 9H), 1.55 (s, 3H), 2.81 (s, 3H), 7.20-7.36 (m, 6H), I668.46 (m, 1H). Compound a-79: 1.93 (s, 3H), 2.77 (s, 3H), 6.59 (s, 1H), 7.25-7.42 (m, 6H), 8.45 (m, 1H).
[0259] Compound a-86: 1.75 (s, 6H), 2.06 (t, 1H), 2.85 (s, 3H), 3.93 (d, 2H), 7.23-7.33 (m, 5H), 8.43 (m, 1H). Compound a-88: 0.8-0.9 (m, 6H), 1.66 (s, 3H), 2.0-2.2 (m, 2H), 2.84 (s, 3H), 3.1-3.4 (m, 2H), 7.19-7.33 (m, 5H), 8.45 (m, 1H). Compound a-96: 1.76 (s, 6H), 2.10 (t, 1H), 2.77 (s, 3H), 3.95 (d, 2H), 7.18-7.25 (m, 3H), 7.5-7.6 (m, 2H), 8.39 (m, 1H). Compound a-98: 1.04 (d, 3H), 1.68 (s, 6H), 2.79 (s, 3H), 3.17 (s, 3H), 3.26 (m, 2H), 4.90 (m, 1H), 7.15-7.23 (m, 2H), 7.26-7.40 (m, 3H), 7.47 (s, 1H), 8.42 (m, 1H). Compound a-104: 1.68 (s, 6H), 2.70 (s, 3H), 3.88 (s, 3H), 6.06 (bs, 1H), 6.91 (d, 1H), 7.14-7.34 (m, 3H), 7.94 (d, 1H), 8.36 (dd, 1H).
[0260] Compound b-1: 7.13(m, 1H), 7.54(m, 1H), 7.69(m, 1H), 7.79(m, 1H), 7.96-8.04(m, 2H), 8.14(d, 1H), 8.25(br, 1H), 8.83(d, 1H). Compound b-5: 1.73 (s, 6H), 2.65 (s, 3H), 3.30 (s, 3 H), 7.06 (m, 1H), 7.3-7.5 (m, 3H), 7.71 (d, 1H), 7.91 (dd, 1H), 7.98 (m, 1H)
[0261] The nitrogen-containing heterocyclic compounds obtained in the above examples, and nitrogen-containing heterocyclic compounds synthesized by the same method as in any of the above examples, are shown in Tables 3 and 4. R in Table 3 1 , R 2 , R 3 , (X 1 ) m A 1 , and (X 2 ) n represents those in equation (2). R in Table 4 1 , R2 , R 3 , (X 1 ) m , B, A 1 , and (X 2 ) n represents those in equation (3). Also, the n listed in the physical properties section. D The symbol indicates the refractive index (the superscript number indicates the measurement temperature (°C)).
[0262]
[0263]
[0264]
[0265]
[0266]
[0267]
[0268]
[0269]
[0270]
[0271] Of the compounds listed in the table above, those marked with an asterisk (*) in the physical properties column: 1 H-NMR (300 MHz, CDCl3)δ was measured. Some of the measurement results are shown below. Compound 1-1: 1.41 (s, 9H), 7.13 (d, 1H), 4.22-7.28 (m, 2H), 7.49 (m, 1H), 7.59-7.69 (m, 2H), 7.80 (d, 1H), 8.07 (d, 1H), 8.67 (s, 1H). Compound 1-2: 1.22 (s, 6H), 1.50 (s, 6H), 1.97 (s, 1H), 7.09 (m, 1H), 7.23-7.33 (m, 2H), 7.57-7.68 (m, 3H), 7.77 (m, 1H), 8.07 (m, 1H), 8.67 (s, 1H). Compound 1-9: 1.58 (d, 3H), 3.00 (s, 3H), 4.95 (q, 1H), 7.13 (m, 1H), 7.28-7.37 (m, 3H), 7.57-7.71 (m, 3H), 8.07 (m, 1H), 8.72 (s, 1H). Compounds 1-17: 1.40 (s, 6H), 2.89 (s, 3H), 5.26 (s, 1H), 7.30 (m, 1H), 7.42 (d, 1H), 7.48-7.61 (m, 2H), 7.86 (m, 1H), 8.55 (d, 1H). Compounds 1-19: 1.05 (d, 6H), 1.54 (s, 6H), 4.75 (m, 1H), 7.28-7.36 (m, 4H), 7.50 (d, 1H), 7.58-7.59 (m, 2H), 8.65 (s, 1H). Compounds 1-24: 1.05 (d, 6H), 1.52 (s, 6H), 4.74 (m, 1H), 7.26-7.36 (m, 3H), 7.48-7.56 (m, 3H), 8.66 (s, 1H). Compounds 1-33: 0.38 (t, 3H), 0.73 (m, 2H), 1.69 (s, 6H), 2.93 (s, 3H), 2.98 (t, 2H), 7.27 (m, 1H), 7.35-7.49 (m, 3H), 7.63 (d, 1H), 8.51 (d, 1H). Compounds 1-34: 1.12 (d, 6H), 1.59 (s, 6H), 4.86 (m, 1H), 6.97-7.05 (m, 2H), 7.25-7.36 (m, 2H), 7.56-7.63 (m, 2H), 8.65 (s, 1H). Compounds 1-42: 0.77 (t, 3H), 1.03 (d, 6H), 1.51 (s, 3H), 2.11 (q, 2H), 4.77 (m, 1H), 7.33 (dd, 1H), 7.50-7.58 (m, 2H), 7.73 (dd, 1H), 8.52 (dd, 1H), 8.70 (s, 1H). Compound 1-68: 1.05 (d, 3H), 1.59 (s, 6H), 3.19 (s, 3H), 3.21-3.30 (m, 2H), 4.95 (m, 1H), 7.33 (dd, 1H), 7.54-7.58 (m, 2H), 7.78 (dd, 1H), 8.51 (dd, 1H), 8.74 (s, 1H). Compound 1-69: 1.58 (s, 6H), 1.75-1.92 (m, 2H), 3.58-3.70 (m, 4H), 4.93 (m, 1H), 7.34 (dd, 1H), 7.54-7.59 (m, 2H), 7.72 (dd, 1H), 8.52 (dd, 1H), 8.72 (s, 1H). Compound 2-4: 1.68 (s, 6H), 1.76-1.82 (m, 2H), 1.86-1.92 (m, 2H), 2.73 (t, 2H), 2.89 (t, 2H), 3.14 (s, 3H), 6.98 (d, 1H), 7.15-7.16 (m, 2H), 8.09 (d, 1H), 8.35 (d, 1H).
[0272] Nitrogen-containing heterocyclic compounds synthesized by a method similar to that of any of the above examples are shown in Tables 5 and 6. R in Table 5 1 , R 2 , R 3 , B, A 1 , and (X 2 ) n represents those in equation (4). R in Table 6 1 , R 2 , R 3 , B, A 1 , and (X 2 ) n represents those in equation (5).
[0273]
[0274]
[0275]
[0276]
[0277] (Formulation) Next, some examples of the fungicide for agricultural and horticultural use according to the present invention are shown, but the additives and their proportions are not limited to these examples and can be varied over a wide range. Also, parts in the formulation examples refer to parts by weight.
[0278] Formulation Example 1: Wettable Powder 40 parts of the compound of the present invention Clay 48 Dioctyl sulfosuccinate sodium salt 4 parts Sodium lignin sulfonate 8 parts The above ingredients are uniformly mixed and finely ground to obtain a wettable powder containing 40% active ingredient.
[0279] Formulation Example 2: Emulsion 10 parts of the compound of the present invention Solvesso 200, 53 copies Cyclohexanone 26 parts Calcium dodecylbenzenesulfonate (part) Polyoxyethylene alkyl allyl ether 10 parts The above ingredients are mixed and dissolved to obtain an emulsion containing 10% of the active ingredient.
[0280] Formulation Example 3 Powder 10 parts of the compound of the present invention Clay 90 copies The above ingredients are uniformly mixed and finely ground to obtain a powder containing 10% of the active ingredient.
[0281] Formulation Example 4: Granules Five parts of the compound of the present invention. Clay 73 Bentonite 20 units Dioctyl sulfosuccinate sodium salt (1 part) Potassium phosphate (partial) The above ingredients are thoroughly crushed and mixed, water is added and kneaded well, and then granulated and dried to obtain granules containing 5% of the active ingredient.
[0282] Formulation Example 5: Suspension 10 parts of the compound of the present invention Polyoxyethylene alkylallyl ether 4 parts Sodium polycarboxylate salt, 2 parts Glycerin 10 parts Xanthan gum 0.2 parts Water 73.8 parts The above ingredients are mixed and wet-ground until the particle size is 3 microns or less to obtain a suspension containing 10% of the active ingredient.
[0283] Formulation Example 6: Granular Wettable Powder 40 parts of the compound of the present invention Clay 36 Potassium chloride 10 parts Alkylbenzenesulfonate sodium salt (part) Sodium lignin sulfonate 8 parts Formaldehyde condensate of alkylbenzene sulfonate sodium salt 5th part The above ingredients are uniformly mixed and finely ground, then an appropriate amount of water is added and kneaded to form a clay-like substance. After granulating the clay-like substance, it is dried to obtain a granular wettable powder containing 40% of the active ingredient.
[0284] (Biological Test Example 1-1) Apple Scab Disease Control Test Apple seedlings (variety "Kokko," 3-4 leaf stage) grown in unglazed pots were sprayed with an emulsion of the compound of the present invention at a concentration of 100 ppm of the active ingredient, and allowed to air dry at room temperature. Subsequently, conidia of the apple scab fungus (Venturia inaequalis) were inoculated, and the seedlings were kept in a room with high humidity at 20°C, with light and dark alternating every 12 hours, for two weeks. The appearance of disease lesions on the leaves was compared with the untreated group to determine the control effect. Compound number a-2, a-3, a-4, a-5, a-6, a-7, a-8, a-9, a-10, a-11, a-12, a-14, a-15, a-16, a-17, a-18, a-19, a-20, a-21, a-22, a-2 3, a-27, a-28, a-29, a-30, a-31, a-32, a-33, a-34, a-35, a-36, a-37, a-38, a-39, a-40, a-41, a-42, a-43, a-44, a-45, a-4 Control tests for apple scab were conducted on compounds 6, a-47, a-48, a-49, a-50, a-51, a-52, a-53, a-54, a-55, a-56, a-74, a-75, a-76, a-77, a-78, a-79, a-80, a-81, a-82, a-83, a-84, a-85, a-86, a-87, a-88, a-89, a-90, a-91, a-92, a-93, a-94, a-95, a-96, b-2, and c-1. As a result, all compounds showed a control efficacy of 75% or more. Compound numbers 1-1, 1-2, 1-4, 1-5, 1-6, 1-7, 1-8, 1-9, 1-10, 1-11, 1-12, 1-14, 1-15, 1-17, 1-18, 1-19, 1-20, 1-21, 1-22, 1-23, 1-24, 1-25, 1-26, 1-27, 1-28, 1-29, 1-30, 1-31, 1-32, 1-33, 1-34, 1-35, 1-36, 1-37, 1-38, 1-39, Control tests for apple scab disease were conducted on compounds 1-40, 1-41, 1-42, 1-43, 1-44, 1-45, 1-46, 1-47, 1-48, 1-49, 1-50, 1-51, 1-52, 1-53, 1-54, 1-55, 1-56, 1-57, 1-58, 1-59, 1-60, 1-61, 1-62, 1-63, 1-64, 1-65, 1-66, 1-67, 1-68, 1-70, and 2-2. As a result, all compounds showed a control efficacy of 75% or more.
[0285] (Biological Test Example 1-2) Apple Scab Disease Control Test Apple seedlings (variety "Kokko," 3-4 leaf stage) grown in unglazed pots were sprayed with an emulsion of the compound of the present invention at a concentration of 125 ppm of the active ingredient, and allowed to air dry at room temperature. Subsequently, conidia of the apple scab fungus (Venturia inaequalis) were inoculated, and the seedlings were kept in a room with high humidity at 20°C, with light and dark alternating every 12 hours, for two weeks. The appearance of disease lesions on the leaves was compared with the untreated seedlings to determine the control effect. Control tests for apple scab disease were conducted on compounds with compound numbers a-97, a-98, a-99, and a-100. As a result, all compounds showed a control efficacy of 75% or more. Control tests for apple scab disease were conducted on compounds numbered 1-69, 1-71, 1-72, 1-73, 1-74, 1-75, 1-76, 1-77, 1-79, and 1-80. As a result, all compounds showed a control efficacy of 75% or more.
[0286] (Biological Test Example 2) Cucumber Gray Mold Control Test Cucumber seedlings (variety "Sagami Hanpaku", cotyledon stage) grown in unglazed pots were sprayed with an emulsion of the compound of the present invention at a concentration of 100 ppm of the active ingredient, and allowed to air dry at room temperature. Subsequently, a conidial suspension of the cucumber gray mold fungus (Botrytis cinerea) was inoculated by drop, and the seedlings were kept in a dark room at 20°C and high humidity for 4 days. The appearance of lesions on the leaves was compared with the untreated group to determine the control effect. Compound number a-2, a-5, a-6, a-7, a-8, a-10, a-11, a-12, a-14, a-15, a-16, a-17, a-18, a-20, a-21, a-22, a-23, a-24, a- 28, a-29, a-30, a-31, a-32, a-33, a-36, a-37, a-38, a-40, a-42, a-43, a-45, a-46, a-48, a-49, a-50, a-51, a-54 Control tests for cucumber gray mold were conducted on compounds a-56, a-74, a-75, a-76, a-77, a-78, a-79, a-80, a-81, a-82, a-83, a-84, a-85, a-86, a-87, a-88, a-90, a-91, a-92, a-93, a-94, a-95, a-96, a-97, a-98, a-99, a-100, a-101, a-102, b-5, and c-1. As a result, all compounds showed a control efficacy of 75% or more. Compound numbers 1-2, 1-4, 1-5, 1-6, 1-7, 1-8, 1-9, 1-10, 1-11, 1-12, 1-13, 1-14, 1-15, 1-16, 1-17, 1-18, 1-19, 1-20, 1-21, 1-22, 1-23, 1-24, 1-25, 1-26, 1-27, 1-28, 1-29, 1-30, 1-31, 1-33, 1-34, 1-35, 1-37, 1-38, 1-39, 1-40, 1-41, 1-42, 1-43, 1-44, 1-45, 1-46, 1-47 Control tests for cucumber gray mold were conducted on compounds 1-48, 1-49, 1-50, 1-51, 1-52, 1-53, 1-54, 1-55, 1-56, 1-57, 1-59, 1-60, 1-61, 1-62, 1-63, 1-64, 1-65, 1-66, 1-67, 1-68, 1-69, 1-70, 1-71, 1-72, 1-73, 1-74, 1-75, 1-76, 1-77, 1-79, 1-80, 1-81, 1-83, 1-84, 1-85, 2-4, and 3-4. As a result, all compounds showed a control efficacy of 75% or more.
[0287] (Biological Test Example 3) Rice Blast Disease Surface Application Test (2 days) Rice seedlings (variety "Koshihikari", 1-leaf stage) were cultivated in pots filled with commercially available potting soil and flooded. An emulsion of the compound of the present invention was drip-treated onto the water surface at a concentration of 400 ppm of the active ingredient. Two days later, a conidial spore suspension of the rice blast fungus (Magnaporthe grisea) was spray-inoculated, and the plants were kept in a dark room at 25°C and high humidity for two days. Subsequently, they were kept in a room at 25°C with alternating light and dark cycles every 12 hours for eight days. The appearance of lesions on the leaves was compared with the untreated group, and the control effect was determined according to the following criteria. A (Control effectiveness of 60% or more) B (Control value of 40% or more but less than 60%) A water surface application test was conducted on compounds a-6, a-38, a-46, a-54, a-92, a-95, and b-1 for rice blast disease. The results showed that compounds a-6, a-38, a-46, a-54, and a-92 had a control effect of A. Compounds a-95 and b-1 had a control effect of B. Water surface application tests were conducted for compounds 1-20, 1-24, 1-35, 1-57, and 1-68 to control rice blast disease. As a result, compounds 1-20, 1-35, 1-57, and 1-68 showed a control effect of A. Compound 1-24 showed a control effect of B.
[0288] (Biological Test Example 4) Rice Blast Disease Surface Application Test (14 days) Rice seedlings (variety "Koshihikari", 1-leaf stage) were cultivated in pots filled with commercially available potting soil and flooded. An emulsion of the compound of the present invention was drip-treated onto the water surface at a concentration of 400 ppm of the active ingredient. After 14 days, a conidial spore suspension of the rice blast fungus (Magnaporthe grisea) was spray-inoculated, and the plants were kept in a dark, 25°C, high-humidity room for 2 days, followed by 8 days in a 25°C room with alternating light and dark cycles every 12 hours. The appearance of lesions on the leaves was compared with the untreated plants, and the control effect was determined according to the following criteria. A (Control effectiveness of 60% or more) B (Control value of 40% or more but less than 60%) A water surface application test was conducted on compounds a-6, a-8, a-12, a-15, a-16, a-23, a-56, a-74, a-86, a-92, and a-94 for rice blast disease. As a result, the control effect of compounds a-6, a-12, a-15, a-16, a-23, a-56, a-74, a-86, a-92, and a-94 was A. The control effect of compound a-8 was B. Surface application tests for rice blast disease were conducted for compounds numbered 1-2, 1-4, 1-5, 1-6, 1-7, 1-10, 1-11, 1-14, 1-15, 1-26, 1-27, 1-29, 1-30, 1-31, 1-35, 1-51, and 1-70. As a result, the control effect of all compounds was rated A.
[0289] (Biological Test Example 5) Seed Treatment Test on Cucumber Seeds Infected with Fusarium wilt Cucumber seeds (variety "Sagami Hanpaku") contaminated with Fusarium oxysporum, the fungus that causes cucumber wilt, were treated with an emulsion of the compound of the present invention at a concentration of 1 g / kg of active ingredient per seed. These seeds were sown, and after three weeks, the degree of disease development was compared with that of an untreated group to determine the control effect. Seed treatment tests were conducted on cucumber seeds infected with Fusarium wilt using compounds a-6, a-7, a-8, a-16, a-38, a-45, a-46, a-54, a-86, a-92, and a-95. As a result, all compounds showed a control efficacy of 75% or more. Seed treatment tests were conducted on cucumber seeds infected with Fusarium wilt using compounds numbered 1-14, 1-15, 1-20, 1-24, 1-30, 1-35, 1-38, 1-57, 1-64, 1-68, and 1-79. As a result, all compounds showed a control efficacy of 75% or more.
[0290] (Biological Test Example 6) Seed Treatment Test in Cucumber Vine Disease-Contaminated Soil Cucumber seeds (variety "Sagami Hanpaku") were treated with an emulsion of the compound of the present invention at a concentration of 1 g / kg of active ingredient per seed. These seeds were sown in soil contaminated with Fusarium oxysporum, a fungus that causes cucumber wilt disease. After three weeks, the degree of disease development was compared with that of an untreated group to determine the control effect. Seed treatment tests were conducted on soil contaminated with cucumber wilt disease using compounds a-7, a-16, a-38, a-45, a-46, a-54, a-86, and a-92. As a result, all compounds showed a control efficacy of 75% or more. Cucumber vine wilt seed treatment tests were conducted on compounds 1-4, 1-5, 1-6, 1-7, 1-14, 1-15, 1-20, 1-24, 1-30, 1-35, 1-57, 1-64, and 1-68. As a result, all compounds showed a control efficacy of 75% or more.
[0291] The nitrogen-containing heterocyclic compound of the present invention is a novel compound useful as an active ingredient in fungicides for agriculture and horticulture. The fungicide for agricultural and horticultural use of the present invention has reliable and excellent control effects, does not cause phytotoxicity to plants, and is a safe agent with low toxicity to humans, livestock, and fish, as well as minimal environmental impact.
Claims
[1] A nitrogen-containing heterocyclic compound represented by formula (I), or a salt thereof. In formula (I), R represents a group represented by CR a , a , b , 1 , 3 , 1 , 3 R 2 R 3 or a cyano group. R 1 ~R 3 are each independently a hydrogen atom, an unsubstituted or substituted C1-8 alkyl group, an unsubstituted or substituted C2-8 alkenyl group, an unsubstituted or substituted C2-8 alkynyl group, an unsubstituted or substituted C3-8 cycloalkyl group, an unsubstituted or substituted C4-8 cycloalkenyl group, an unsubstituted or substituted C6-10 aryl group, an unsubstituted or substituted heterocyclic group, an unsubstituted or substituted C1-8 acyl group, an unsubstituted or substituted (1-imino)C1-8 alkyl group, an unsubstituted or substituted carboxyl group, an unsubstituted or substituted carbamoyl group, an unsubstituted or substituted hydroxyl group, an unsubstituted or substituted amino group, an unsubstituted or substituted mercapto group, a substituted sulfonyl group, a halogeno group, a cyano group, or a nitro group. However, R 1 ~R 3 are not all hydrogen atoms. Also, R 1 ~R 3 are not all unsubstituted C1-8 alkyl groups. Also, when any one of R 1 ~R 3 is a hydrogen atom, the remaining two are not all unsubstituted C1-8 alkyl groups. Also, when any one of R 1 ~R 3 is an unsubstituted C1-8 alkyl group, the remaining two are not all hydrogen atoms. Also, R 1 ~R 3 may together form an unsubstituted or substituted 5-8 membered ring, or a group represented by =O, =CR a R b (R a and R b Each of these independently represents a hydrogen atom or an unsubstituted or substituted C1-8 alkyl group. Alternatively, they may form a group represented as =N-R' (where R' represents an unsubstituted or substituted hydroxyl group or an unsubstituted or substituted C1-8 alkyl group). X 1 Each of these independently represents an unsubstituted or substituted C1-8 alkyl group, an unsubstituted or substituted C2-8 alkenyl group, an unsubstituted or substituted C2-8 alkynyl group, an unsubstituted or substituted hydroxyl group, a halogeno group, a cyano group, or a nitro group. m is X 1 This indicates the number of items and is an integer between 0 and 5. X 2 Each of these independently represents an unsubstituted or substituted C1-8 alkyl group, an unsubstituted or substituted C2-8 alkenyl group, an unsubstituted or substituted C2-8 alkynyl group, an unsubstituted or substituted C3-8 cycloalkyl group, an unsubstituted or substituted C4-8 cycloalkenyl group, an unsubstituted or substituted C6-10 aryl group, an unsubstituted or substituted heterocyclic group, an unsubstituted or substituted C1-8 acyl group, an unsubstituted or substituted (1-imino)C1-8 alkyl group, an unsubstituted or substituted carboxyl group, an unsubstituted or substituted carbamoyl group, an unsubstituted or substituted hydroxyl group, an unsubstituted or substituted amino group, an unsubstituted or substituted mercapto group, a substituted sulfonyl group, a halogeno group, a cyano group, or a nitro group. n is X 2 This indicates the number of items and is an integer between 0 and 3. R 1 ~R 3 One of the following, X 2 It may combine with any one of the following to form an unsubstituted or substituted 5- to 8-membered ring. B represents a carbon atom or a nitrogen atom. D is either unsubstituted or X 1 A 5-7 member hydrocarbon ring substituted with, or unsubstituted or X 1 This shows a 5- to 7-membered heteroring substituted with [the specified component]. A 1 A 2 A 3 , and A 4 Each of these independently represents either a carbon atom or a nitrogen atom. However, if B is a carbon atom, then A 1 ~A 4 It is not entirely composed of carbon atoms. [2] The nitrogen-containing heterocyclic compound or salt thereof according to claim 1, characterized in that D in formula (I) represents a benzene ring. [3] A in formula (I) above 1 This indicates a nitrogen atom, A 2 A 3 , and A 4 The nitrogen-containing heterocyclic compound or salt thereof according to claim 2, characterized in that it represents a carbon atom. [4] The nitrogen-containing heterocyclic compound or salt thereof according to claim 3, characterized in that B in formula (I) represents a carbon atom. [5] In formula (I) above, B represents a nitrogen atom, and A 2 A 3 , and A 4 The nitrogen-containing heterocyclic compound or salt thereof according to claim 2, characterized in that it represents a carbon atom. [6] A in formula (I) above 1 The nitrogen-containing heterocyclic compound or salt thereof according to claim 5, characterized in that it represents a nitrogen atom. [7] A fungicide for agricultural and horticultural use containing at least one selected from the group consisting of nitrogen-containing heterocyclic compounds and salts thereof as described in any one of claims 1 to 6, as an active ingredient.
